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 -1- SUMMARY 
1. Summary 
More than 200,000 plant natural products (PNPs) are currently known. As many of them 
have favorable effects in the treatment of various diseases such as cancer, diabetes and 
heart diseases, PNPs are of high interest for the development of new pharmaceutical drugs. 
A major obstacle during drug development is the limited availability of most PNPs. In 
comparison to purification from the respective plant sources or costly chemical synthesis, 
the microbial production of these compounds could provide sufficient quantities from 
inexpensive substrates.  
The main goal of this thesis was the development of a microbial production platform for the 
synthesis of pinosylvin, a stilbene found in the heartwood of pine trees (e.g. Pinus strobus 
and Pinus sylvestris) in Escherichia coli from L-phenylalanine. The first step in the 
biosynthetic pathway is the deamination of L-phenylalanine to trans-cinnamic acid, which is 
catalyzed by a phenylalanine ammonia lyase. The resulting acid is subsequently activated by 
a 4-coumarate-CoA ligase yielding the coenzyme A thioester trans-cinnamoyl-CoA. A stilbene 
synthase catalyzes the successive condensation of three malonyl-CoA molecules with trans-
cinnamoyl-CoA and the cyclization of the resulting linear tetraketide intermediate to form 
the stilbene pinosylvin. Initially, two different variants for each of the three enzymes 
towards pinosylvin were selected on the basis of their biochemical characteristics. After the 
construction of several pathway variants and optimization of gene expression, pinosylvin 
concentrations of up to 3 mg/L were detected by HPLC-MS analysis of ethyl acetate extracts 
from culture supernatants, showing that the plant pathway was functional in E. coli. Analysis 
of precursor availability and a comparative analysis of intracellular levels of pathway 
intermediates and product identified limited malonyl-CoA availability and low activity of the 
pine-derived stilbene synthase as key bottlenecks. By increasing malonyl-CoA availability 
through addition of the fatty acid synthase inhibitor cerulenin and by in vivo evolution of the 
stilbene synthase from Pinus strobus for enhanced activity in E. coli, the pinosylvin titer 
could be increased up to 70 mg/L. A further increase up to 91 mg/L was achieved by 
supplementation of the precursor L-phenylalanine to the medium. 
 
 -2- SUMMARY 
The functional integration of synthetic pathways into the microbial host cell metabolism and 
optimization of heterologous gene expression for achieving high product titers is still a 
challenging task during metabolic engineering. With the aim to develop a tool for the 
construction and balancing of synthetic pathways, we advanced the Phosphorothioate Ligase 
Independent Gene Cloning (PLICing) technique and optimized the expression of a 
polycistronic operon encoding tyrosine ammonia lyase, 4-coumarate-CoA ligase, cinnamoyl-
CoA reductase, and cinnamyl alcohol dehydrogenase. These four enzymes catalyze the 
formation of p-coumaryl alcohol from L-tyrosine in E. coli. The PLICing method proved to be 
a fast and efficient technique for the combinatorial assembly of multiple pathway 
configurations when constructing each pathway configuration individually. A protocol 
developed for the rapid simultaneous construction of a complete operon library 
encompassing all possible pathway configurations proved to be unfeasible due to a 
decreased assembly accuracy of complete operons. Systematic variation of the spacing 
between the Shine-Dalgarno sequence and the start codon efficiently modulated the 
translation efficiency of individual pathway genes and helped to balance the synthesis of the 
p-coumaryl alcohol pathway enzymes to achieve high product titers. During the evaluation 
of 81 pathway variants, tyrosine ammonia lyase activity proved to be the limiting step. 
Maximization of the translation efficiency of the respective mRNA was decisive for the 
construction of an E. coli strain, which accumulated up to 52 mg/L p-coumaryl alcohol in the 
supernatant. 
 
 -3- INTRODUCTION 
2. Introduction 
2.1. Plant natural products 
Plant natural products (PNPs) are plant secondary metabolites that are not essential for 
plant survival, but aid in the growth and development of the plant in its environment. PNPs 
play an important role in plant defense, signaling and regulation of metabolic activity within 
plant cells, but are also responsible for the characteristic colors and fragrances of plants (1). 
  
 
Figure 2.1 Schematic overview of biosynthetic routes leading to the five major classes of plant 
natural products (PNPs) starting from primary metabolism precursors. Color-code reflects the origin 
of the different PNP classes from fatty acid-, sugar- or amino acid metabolism.  
PNPs are derived from primary metabolites, which are formed during the fatty acid, sugar or 
amino acid metabolism (Figure 2.1). Basically five major classes of PNPs can be distinguished: 
isoprenoids, alkaloids, glucosinolates, polyacetylenes and phenylpropanoid and 
phenylpropanoid-derived polyphenols (1). 
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2.1.1. Isoprenoids 
Isoprenoids also known as terpenoids represent the largest class of PNPs with more than 
40,000 compounds estimated to exist in nature (2). Their biological function in nature ranges 
from light-harvesting in photosynthesis to acting as attractants, repellents, toxins or 
antibiotics in the context of reproduction, defense or symbiosis with other organisms (3). 
Plant terpenoids have been widely applied in the pharmaceutical, food, cosmetics, flavors 
and fragrance, pesticide and disinfectant industry. For example menthol, a monoterpene 
(C10) that is widely used in the flavor and fragrance industry, has an annual production of 
12,000 tons per year (4). Other noteworthy examples of isoprenoids are the antimalarial 
drug artemisinin, a sesquiterpene (C15) lactone bearing a peroxide bridge isolated from the 
plant Artemisia annua (5) and the anticancer drug taxol, a diterpene (C20) originally isolated 
from the bark of the Pacific yew, Taxus brevifolia (6)(Figure 2.2).  
Two pathways are known for the biosynthesis of isoprene building blocks: [1] the mevalonic 
acid (MEV) pathway, which is utilized by mammals, higher plant species (in the cytosol), 
archaea and some gram-positive bacteria and [2] the 2C-methyl-D-erythritol-4-phosphate 
(MEP) pathway, which can be found in higher plants (in the plastids), a few gram-positive 
bacteria and most gram-negative bacteria (7). Isoprenoids are synthesized by consecutive 
condensations of the five-carbon isoprene building blocks, isopentenyl pyrophosphate (IPP), 
with its isomer, dimethylallyl pyrophosphate (DMAPP). Terpenoids are classified on the basis 
of the number of isoprene units present in their structure. The smallest terpenoids, the 
hemiterpenoids (C5) can be formed directly from DMAPP by terpenoid synthase (TPS) activity 
(8), while consecutive condensation steps of two, three and four isoprene units are catalyzed 
by prenyl transferases (PT) yielding geranyldiphosphate (GDP; C10), farnesyl diphsophate 
(FDP; C15) and geranylgeranyl diphosphate (GGDP; C20), respectively (9). TPS enzymes 
convert GDP, FDP and GGDP into monoterpenoids (C10), sesquiterpenoids (C15) and 
diterpenoids (C20), in that order. Furthermore, condensation of two molecules of FDP or 
GGDP gives rise to the precursors of the triterpenoid (C30) and tetraterpenoid (C40) classes. 
The basic structures of the hemi (C5)-, mono (C10)-, sesqui (C15)- and diterpenes (C20), can be 
further functionalized by various cytochrome P450- dependent mono-oxygenases (P450), 
reductases, dehydrogenases or numerous classes of transferases, which catalyze 
oxidations/hydroxylations, reductions, oxidations/dehydrogenations and transfer functional 
groups (e.g. acyl, aroyl) to the basic structures of terpenoids, respectively (2). 
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2.1.2. Alkaloids 
Alkaloids are low molecular weight nitrogen containing compounds, which are usually 
derived from amino acids (Figure 2.2). They can be divided into five groups dependent on 
the amino acid of origin (amino acid or amine pre-cursor is given in brackets): 
I. tropane-, pyrrolidine- and pyrrolizide-alkaloids (ornithine), 
II. benzylisoquinoline (tyrosine), 
III. indolequinoline (tryptophan), 
IV. pyridine (pyridine), and 
V. quinolizidine- and piperidine-alkaloids (lysine). 
The biosynthetic pathways for alkaloid production usually comprise many enzymatic steps, 
e.g. 30 enzymes are involved in the biosynthesis of the monoterpenoid indole alkaloid 
vincristine from tryptophan and geraniol (10). In plants over 12,000 alkaloids have been 
described to date and most of the known functions of alkaloids are related to plant defense. 
They often have pharmacological effects and are used as medication (e.g. morphine as 
analgesic and vincristine as anticancer agent), as recreational drug (cocaine) or stimulant 
(caffeine and nicotine) (11). 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Exemplary structures of PNPs belonging to the group of isoprenoids (artemisinin and 
taxol), alkaloids (morphine and cocaine) and polyacetylenes (tariric acid).
Artemisinin Taxol Morphine 
Cocaine Tariric acid 
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2.1.3. Glucosinolates  
Glucosinolates represent only a small group of around 120 described structures that contain 
sulfur and nitrogen and are derived from glucose and an amino acid. Glucosinolates are 
plant secondary metabolites well-known for their role in plant defense against insects and 
pathogens, while for humans these compounds function as biopesticides, flavor compounds 
and also have a large potential as cancer-preventing agents (12).  
 
Figure 2.3 Glucosinolate core structure. Variable R group is determined by the side chain of the 
precursor amino acid.  
Upon plant damage glucosinolates are hydrolized to a variety of products that are 
responsible for all biological activities of this class of compounds. The first hydrolysis step is 
catalyzed by a thioglucoside glucohydrolase termed myrosinase, leading to the formation of 
glucose and an unstable aglycone. The aglycone rearranges to form different products, 
including isothiocyanates, oxazolidine-2-thiones, nitriles, epithionitriles, and thiocyanates, 
depending on the structure of the amino acid side chain and the presence of additional 
proteins and cofactors. Glucosinolates can be classified into three groups by their amino acid 
precursor: [1] compounds derived from L-alanine, L-leucine, L-isoleucine, L-methionine or L-
valine are called aliphatic glucosinolates, [2] those derived from L-phenylalanine and L-
tyrosine are called aromatic or benzenic glucosinolates, and [3] those derived from L-
tryptophan are called indole glucosinolates (12). Glucosinolates have been exclusively found 
in the order Brassicales (Capparales) and the family Putranjivaceae (Euphorbiaceae). The 
biosynthesis of glucosinolates proceeds through three separate phases: [1] chain elongation 
of the amino acid side group by methylene (–CH2–) moieties can occur for L-methionine and 
L-phenylalanine amino acid precursors, [2] formation of the core glucosinolate structure 
(Figure 2.3, a β-D-glucopyranose residue linked via a sulfur atom to a (Z )-N-
hydroximinosulfate ester, plus a variable R group determined by the amino acid side chain) 
and [3] secondary modification of the amino acid side chain. For aliphatic glucosinolates, 
secondary modifications include oxygenations, hydroxylations, alkenylations and 
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benzoylations, whereas indolic glucosinolates, can undergo hydroxylations and 
methoxylations (13). 
2.1.4. Polyacetylenes 
To date more than 2,000 polyacetylenes have been identified, which are characterized by 
their carbon-carbon triple bond(s) or alkynyl functional group(s) (Figure 2.2). Studies 
concerning their ecological function hint at survival-based roles were they can act as toxin, 
anti-feedant, allelochemical, phytoalexin or antibiotic (14), but especially their antitumor 
properties have attracted significant research attention (15). Fatty acids produced during the 
primary metabolism represent the substrates for polyacetylene biosynthesis. The main 
mechanism for unsaturated carbon-carbon bond formation in plants is the oxidative 
dehydrogenation (desaturation) mechanism, catalyzed by non-hemediiron desaturases, 
which consume molecular oxygen and electrons provided by either NADH or NADPH to 
excise two vicinal C–H bonds on the alkyl chain of a fatty acid derivative, while 
simultaneously reducing oxygen to water (14). 
2.1.5. Phenylpropanoid and phenylpropanoid-derived polyphenols  
Phenylpropanoids (PPs) and PP-derived compounds represent the major source of plant 
phenolic compounds. PP-derived products can provide protection against ultraviolet light, 
pathogens and herbivores, but can also serve as plant pigments and fragrances (16). In 
addition to these qualities, their health promoting effects such as antioxidant, antiviral, 
antibacterial and anticancer activities, makes them very interesting compounds for the 
pharmaceutical industry. Furthermore, PP and PP-derived products could be used as 
aromatic chemical building blocks in the fine chemical, materials synthesis, and flavor and 
fragrance industries (1).  
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Figure 2.4 Modular overview of biosynthetic pathways for the production of phenylpropanoid pre-
cursor structures (blue), stilbenes (orange), lignans (purple) and flavonoids (red). Abbreviations: 4CL, 
4-coumaryl-CoA ligase; C4H, cinnamate 4-hydroxylase; CAD, cinnamyl alcohol dehydrogenase; CCR, 
cinnamoyl-CoA reductase; CHI, chalcone isomerase; CHS, chalcone synthase; DIR, dirigent protein; 
LAC, laccase; MON, cytochrome P450 monooxygenase; OMT, O-methyltransferase; PAL, 
phenylalanine ammonia lyase; STS, stilbene synthase; TAL, tyrosine ammonia lyase. 
Characteristic for the PP structure is their aromatic phenyl group and propene tail, which are 
derived from the precursor amino acids L-tyrosine and L-phenylalanine. The first step of the 
phenylpropanoid biosynthesis pathway is catalyzed by a phenylalanine ammonia lyase (PAL) 
or a tyrosine ammonia lyase (TAL), which converts L-phenylalanine into trans-cinnamic acid 
or L-tyrosine into p-coumaric acid through a non-oxidative deamination, respectively (Figure 
2.4). Trans-cinnamic acid can be converted to p-coumaric acid by a cinnamate 4-hydroxylase 
(C4H). Subsequently, both acids can be modified by Coenzyme A (CoA) activation, reduction, 
O-methylation and/or aromatic hydroxylation to give rise to precursor molecules for the 
synthesis of flavonoids, stilbenes, coumarins and lignans. Phenylpropanoids are either direct 
precursors of lignans and coumarins or are incorporated into the stilbene and flavonoid 
structures, through a hybrid phenylpropanoid/polyketide-pathway requiring malonyl-CoA 
(Figure 2.4). Whether a stilbene or a flavonoid is formed, depends on the type III polyketide 
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synthase. Either a stilbene synthase (STS) or a chalcone synthase (CHS), catalyzes the 
iterative condensation of three malonyl-CoA units to a CoA-activated phenylpropanoic acid 
(16). However, the resulting tetraketide intermediate is either cyclized via an intramolecular 
C2  C7 aldol condensation under direction of the STS to form a stilbene, or an 
intramolecular C6 C1 claisen condensation to form a chalcone under guidance of the CHS. 
An additional ring closing step catalyzed by a chalcone isomerase (CHI), converts the 
chalcone to the core flavonoid structure. Further modifications such as hydroxylations, 
methylations, methoxylations, acylations and C- and/or O-glycosylations give rise to the 
different classes of flavonoids (16). Quercetin, a flavonol (17) and the stilbene resveratrol 
(18) have been extensively studied for their antioxidant, anti-inflammatory, anti-cancer and 
other health promoting effects (Figure 2.5). 
 
 Figure 2.5 The flavonol quercetin, the stilbene resveratrol and (-)-enterolactone, a lignin which is 
formed from plant lignans by the action of mammalian intestinal bacteria. 
A general scheme for coumarin biosynthesis has been inferred, even though the genes 
encoding the enzymes of even the simplest coumarin structure still have to be identified 
(Figure 2.6). Generally the coumarin biosynthesis starts from L-phenylalanine via the 
intermediates trans-cinnamate, trans-2-coumarate, trans-2-coumarate-β-D-glucoside, cis-2-
coumarate-β-D-glucoside, and cis-2-coumarate (19). From a health perspective coumarins 
have received most attention for their antioxidant properties (20). 
 
Figure 2.6 Proposed coumarin biosynthetic pathway in plants. Abbreviations: PAL, phenylalanine 
ammonia lyase; C2H, cinnamate 2-hydroxylase; 2GT, 2-coumarate-O-β-glucosyltransferase, GBA, β-
glucosidase (19).  
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Reduction of CoA-activated phenylpropanoic acids leads to the formation of monolignols. 
Subsequently occurring reductions are catalyzed by a cinnamoyl-CoA reductase (CCR) and a 
cinnamyl-alcohol dehydrogenase (CAD), while hydroxylases and methyltransferases can 
modify the intermediates to yield the various monolignol structures (21). Monolignols are 
precursors of lignin, which give plant cell walls their mechanical strength, and of the 
structurally diverse group of lignans (22). The main components of lignin are the monolignols 
coniferyl alcohol, sinapyl alcohol and p-coumaryl alcohol (21). Lignans or dilignols are formed 
through the oxidative dimerization of two monolignol units. Monolignol dimerization is 
initiated by laccases or peroxidases, resulting in the formation of free radical intermediates. 
The patterns of dimerization are controlled by so-called dirigent proteins (DIRs). DIRs 
capture and position the free radicals, to enable formation of only one specific dilignol 
species (23). Enterolactone (Figure 2.5) formed in the mammalian digestive tract from plant 
lignans has also been identified as potential anti-cancer agent (24).  
2.2. Production of plant natural products 
As has been outlined above, PNPs have a multitude of different properties that have made 
them attractive for the use in pharmaceutical, food, cosmetics, flavors and fragrance, 
materials synthesis, pesticide and disinfectant industries. For example almost half of all new 
approved drugs from 1981 to 2010 were (plant) natural products, their semisynthetic 
derivatives or natural product analogs (25). Sufficient production of PNPs is of great 
importance for their sustained commercial use. Three strategies can be employed to 
produce PNPs: (i) extraction from the respective plant sources or from plant cell cultures; (ii) 
synthetic and semi-synthetic approaches can be employed for the chemical synthesis and 
(iii) production in genetically engineered microbial host systems.  
2.2.1. Plant based production 
Solvent extraction of plant material is the most classical method for gaining access to PNPs. 
Some of the commonly used solvents in the extraction procedures such as hexane, ether, 
chloroform, acetonitrile, benzene or ethanol are generally used in different ratios with water 
(26). However, PNPs are usually synthesized in specific types of plant cells (e.g. resveratrol 
can be found in the skin of grapes (27), but also in the roots of the Japanese knotweed (28)) 
and only during a certain developmental stage of the plant, or under specific (seasonal) 
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conditions. The low abundance of most PNPs in natural material and environmental, 
seasonal, or regional variations of natural sources makes their isolation from plant material 
difficult and expensive. Downstream processing is further impeded by the presence of 
structurally similar PNPs. Traditional plant breeding or construction of genetically modified 
(GM) plants can be employed to increase the abundance of a specific PNP (29). However, 
commercialization of PNPs through the use of GM plants is often avoided, due to limited 
customer acceptance and high regulatory hurdles, which must be overcome (30). As an 
alternative to field crops, plant tissue culture systems such as hairy root cultures and cell 
suspension cultures can be used, which produce the PNP of interest either constitutively or 
after elicitation (e.g. UV light, methyljasmonate (31) a signaling molecule derived from plant 
fatty acids) (32). In comparison to field crops, the genetic modification of tissue cultures is 
not as strictly regulated by law and cultivation conditions can be more easily controlled (30). 
Although there are some successful commercial applications of cell suspension cultures (e.g. 
taxol production by plant cell cultures of T. chinensis (33)), the technique still suffers from 
low and variable product yields, slow growth of cultures, biochemical or genetic instability 
over time and scale-up issues (33, 34). 
2.2.2. Chemical synthesis 
Historically, chemical synthesis or semi-synthesis from isolated natural precursors has been 
used for the production of PNP synthetic analogues, owing to their lack of availability or 
expensive isolation from natural sources (35). However, increasing customer demand for 
naturally sourced flavors and colorants in the food industry has diminished the popularity of 
their synthetic alternatives (36). Furthermore, chemical synthesis mostly relies on 
petroleum-derived solvents and chemicals, which is a limited resource. The structural 
complexity of most PNPs, which can include multiple stereo-chemical centers and regio-
specific modifications, represents a tremendous challenge for their chemical synthesis even 
with the advancements in (catalytic) synthetic methods. The complex chemistry of PNPs 
often requires numerous intermediary protection and re-functionalization steps that do not 
lead directly to the targeted molecular structure, but ultimately create an amplitude of 
waste and by-products while the overall yield decreases (37). 
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Figure 2.7 Comparison of microbial PNP production to the more traditional plant based PNP 
production and chemical synthesis of PNPs. 
2.2.3. Microbial production 
Since the first half of the last century microorganisms have been increasingly used for the 
production of value-added compounds for the pharmaceutical, chemical, agricultural and 
food industries (38). The gram negative bacteria Escherichia coli and the yeast 
Saccharomyces cerevisiae are two of the most widely used industrial organisms due to their 
extensively characterized physiology and genetics, high growth rates, and the availability of 
ample genetic tools. Other well-known industrial platform organisms include 
Corynebacterium glutamicum, Bacillus subtilis and Pseudomonas putida (39). The genetic 
accessibility of these microorganisms allows for the construction of tailor-made recombinant 
strains by metabolic engineering, which are able to produce compounds of interest. 
Heterologous production of PNPs is only possible when the metabolic pathway towards the 
PNP is known, so that the specific pathway genes can be transferred to the heterologous 
host. Progress in the field of sequencing and recombinant DNA technology has resulted in 
the elucidation of numerous biosynthetic pathways responsible for the production of PNPs 
(40). Microbial production of PNPs represents a promising alternative with several 
advantages in comparison to above-mentioned approaches (Figure 2.7). First, the PNP 
production proceeds in a benign aqueous environment based on inexpensive renewable 
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feed stocks, avoiding the use of heavy metals, organic solvents, and strong acids and bases, 
which are routinely employed during chemical synthesis (1). Additionally, consumer value is 
increased as flavor and coloring agents produced by microbes are labelled as ‘natural’ (35). 
Furthermore, in contrast to natural product synthesis in plants and plant cell cultures, 
microbial production allows for short production times due their high growth rates. 
Microbial fermentations are also readily scalable from the lab bench to industrial-sized 
fermenters. Finally, downstream purification of PNPs is minimized in comparison to plant 
and plant cell cultures, because in most cases the bacterial host does not have pathways 
competing with the transgenic plant pathway, resulting in the production of chemically 
distinct compounds (41). 
2.3. Metabolic engineering strategies for microbial PNP strain development 
Traditionally, strain development is achieved through iterative rounds of random 
mutagenesis and selection on the basis of desired phenotypic traits. The advantage of this 
approach is that strain improvement is possible without knowledge of the biochemical 
pathways or genetics of the organism, even though this method can be time and resource-
intensive and is only applicable for homologous product pathways when no genetic 
knowledge of the desired biosynthetic pathway is available. With the advent of recombinant 
DNA technologies and the many advances in the field of DNA sequencing and bioinformatics, 
it has become possible to transfer complete biosynthetic pathways from native hosts into 
heterologous microbial organisms. This has paved the way towards microbial PNP 
production. When choosing a heterologous host for the introduction of a PNP pathway, 
several points must be taken into account: [1] genetic accessibility of the expression host, [2] 
availability of biosynthetic precursors, [3] presence of competing metabolic pathways, [4] 
recognition of codon usage and other genetic elements by the transcription and translation 
machinery, [5] necessity of post-translational modifications, [6] tolerance against 
intermediate(s) and product toxicity (42, 43). Multiple metabolic engineering strategies for 
fine tuning of the resultant recombinant organisms exist, in order to obtain high titers of 
desired products. These strategies include, increasing precursor and co-factor supply, 
overexpression of rate limiting enzymes, optimizing and balancing of gene expression, 
plasmid or genome based expression, removal or reduction of flux to unwanted byproducts 
or competing pathways, improving product export or a combination of the above (Figure 
2.8) (40). With the advent of organism specific metabolic models, scientists have started to 
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predict genetic modifications, which should maximize the flux toward a desired product. The 
models take into account all biotransformations present in the production strain and can be 
used to identify targets for genetic modification that are not directly linked to the 
biosynthetic pathway of interest (44, 45). 
 
Figure 2.8 Metabolic engineering strategies for improving product titers during microbial 
biosynthesis. A represents the precursor molecule, B and C the intermediates of the heterologous 
pathway and D corresponds to the product. E1, E2 and E3 represent the heterologously expressed 
enzymes. 
A successful metabolic engineering example for the microbial production of PNPs is the 
production of the terpenoid artemisinic acid, a precursor of the antimalarial drug artemisinin 
with Saccharomyces cerevisiae (Figure 2.9) (46). Engineering strategies used, included 
downregulation of the competing pathway for the precursor molecule farnesyl diphosphate, 
low expression of the reductase (CPR1) and cytochrome b5 (CYB5) from Artemisia annua to 
improve the activity of the amorphadiene oxidase CYP71AV1 (a cytochrome P450), 
overexpression of a cytosolic catalase to reduce oxidative stress and changing from a 
galactose inducible system to constitutive expression of genes involved in the biosynthesis of 
artemisinic acid. Finally process improvements involving an extractive fermentation with 
isopropyl myristate oil and pulse-feeding of ethanol resulted in 25 g/L artemisinic acid (46). 
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Figure 2.9 (a) General scheme for artemisinic acid production in Saccharomyces cerevsiae. Genes 
changed from a galactose inducible system to a constitutive expression system are shown in green. 
Copper- or methionine-repressed squalene synthase (ERG9), to downregulate the competing 
pathway for the precursor molecule farnesyl diphosphate, is shown in red. DMAPP, dimethylallyl 
diphosphate; FPP, farnesyl diphosphate; IPP, isopentenyl diphosphate. tHMG1 encodes truncated 
HMG-CoA reductase. (b) The three-step oxidation pathway of amorphadiene to artemisinic acid from 
Artemisia annua expressed in S. cerevisiae. Taken from C.J. Paddon et al (46).  
2.4. Tools for synthetic pathway assembly 
Plant natural product pathways are multi-gene biosynthetic routes and transfer of such 
pathways to heterologous hosts is greatly facilitated by efficient cloning/assembly 
techniques. The most commonly used cloning technique relies on the activity of restriction 
enzymes to generate compatible ends (‘‘sticky or blunt ends”) and a ligase to fuse the DNA 
fragments that encode the various pathway genes, regulatory elements and expression 
vector (47). However, for assembling multiple DNA fragments into a single plasmid the 
method is limited by the availability of unique restriction sites, varied transformation 
efficiency due to incomplete enzymatic reactions and poor annealing efficiencies of the short 
single stranded DNA (ssDNA) overhangs (2-4 nucleotides) (48). To address these challenges, 
enzyme/ligase-free methods have been developed to enable assembly of multiple genetic 
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components (open reading frames, fusion tags and control elements such as promoters, 
terminators and ribosome binding sites) in a single step (49, 50). The restriction 
enzyme/ligase-free methods are generally based on hybridization of ssDNA overhangs or 
rely on phage recombinases which take advantage of the presence of specific recombination 
sequences (Gateway cloning (51)) or homologous regions between the fragments (Seamless 
Ligation Cloning Extract [SLICE] method (52)). The downside of the recombinase based 
cloning methods, especially of the Gateway cloning method, is that they heavily rely on kits 
containing special vectors, enzymes, or hosts. The restriction enzyme/ligase-free methods 
based on hybridization of ssDNA overhangs differ in the procedures leading to single-
stranded complementary overhangs of the DNA. Generation of these ssDNA overhangs can 
be achieved with exonucleases or enzymes with exonuclease activity e.g. T4 DNA 
polymerase used in Sequence and Ligation Independent Cloning (SLIC) (53) or Ligation 
Independent Cloning (LIC) (54, 55), exonuclease III (56), T7 gene 6 exonuclease (57) or a 
uracil-DNA glycosylase combined with endonuclease VIII applied in the Uracil-Specific 
Excision Reagent (USER) cloning method (58). ssDNA overhangs can also be obtained 
through incomplete PCR (iPCR) generating unfinished extension products (59). Another 
method relying exclusively on PCR is the Circular Polymerase Extension Cloning (CPEC), 
where vector and inserts share overlapping regions at the ends. After denaturation and 
annealing in each CPEC PCR cycle, the inserts and vector hybridize because of their 
compatible ends and use each other as a template during PCR extension (Figure 2.10) (60). 
 
Figure 2.10 Circular Polymerase Extension Cloning (CPEC) principle. 
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Finally, ssDNA overhangs can be obtained via chemical cleavage when utilizing 
phosphorothioate modified nucleotides (61, 62). The method also known as 
Phosphorothioate-based ligase-independent gene cloning (PLICing) starts with the 
amplification of the insert fragment(s) and the vector by PCR using primers with 
phosphorothioated nucleotides at the 5’-end. The PCR products are chemically cleaved in an 
iodine/ethanol buffer, producing single stranded complementary overhangs. The resulting 
fragments are hybridized at room temperature and can be directly transformed into 
competent E. coli cells, were the natural repair system of this bacterium repairs the single 
stranded breaks (nicks) in the plasmid at the overlaps between the individual fragments 
(Figure 2.11) (61, 63). 
 
Figure 2.11 DNA backbone with a phosphorothioate bond (left) and schematic overview of the 
PLICing method composed of four steps: amplification, cleavage, hybridization and transformation 
(right). 
2.5 Aims of this thesis 
This dissertation focused on metabolic engineering strategies for the establishment and 
optimization of phenylpropanoid derived compound production in E. coli. Various studies 
have shown that the stilbene, pinosylvin, could potentially be applied in the treatment of 
certain cancers, cardiovascular inflammatory diseases and adjuvant arthritis (64-67). The 
main goal of this work was to establish and optimize the heterologous production of 
pinosylvin in the platform organism Escherichia coli. Multiple genes and 
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pathway configurations, but also the availability of precursors and intermediates were 
examined. Finally, laboratory protein evolution was performed to optimize the pinosylvin 
production from glucose in E. coli.  
Introduction of heterologous pathways into microbial production strains can be challenging 
due to an unbalanced expression of the pathway genes, which could potentially lead to the 
accumulation of toxic intermediates or the formation of inclusion bodies (68). Therefore, an 
additional aim of this thesis was the development of the Phosphorothioate ligase 
independent gene cloning (PLICing) method to assemble synthetic pathways and balance the 
heterologous gene expression in E. coli (61). To achieve this goal, the PLICing method was 
used to construct a library of synthetic operons, in which the distance between the Shine 
Dalgarno (SD) sequence and the translation initiation codon of four genes associated with 
the biosynthetic production of the monolignol p-coumaryl alcohol, was individually varied.  
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3. Results 
The state of the art of metabolic engineering of microorganisms for the synthesis of 
phenylpropanoid-derived compounds (flavonoids, stilbenes, coumarins and lignans) has 
been reviewed in the following publication entitled ‘’Putting bugs to the blush: metabolic 
engineering for phenylpropanoid-derived products in microorganisms’’. The experimental 
results have been summarized in two publications, one is accepted and one was recently 
submitted.   
In the first paper "Metabolic engineering of Escherichia coli for the synthesis of the plant 
polyphenol pinosylvin", approaches and strategies of metabolic engineering and protein 
evolution for establishing and optimizing the production of the plant stilbenoid pinosylvin 
from L-phenylalanine in E. coli were employed. At first, two enzymes for each of the three 
required enzymatic steps from L-phenylalanine to pinosylvin were selected on the basis of 
published biochemical parameters. The codon optimized genes of the respective enzymes 
were cloned and the basic expression parameters such as expression temperature, 
expression time and inducer concentration were optimized. At this point very low product 
concentrations of 0.068 ± 0.004 mg/L could be measured. Based on these initial 
experiments, the genetic organization of the synthetic pinosylvin pathway was varied to 
identify the most suitable pathway configuration. The construct environment was varied 
through the use of different promoter systems (the T7 promoter from the T7 bacteriophage 
and the constitutive promoter of the glyceraldehyde-3-phosphate dehydrogenase gene [Pgap] 
from E. coli MG1655) and operon or individual expression set-ups. Finally, analysis of 
precursor, intermediates and, product concentrations during the microbial production of 
pinosylvin led to the identification of malonyl-CoA and the stilbene synthase (STS) from Pinus 
strobus as bottlenecks during product formation. Shortage of malonyl-CoA could be 
circumvented by adding cerulenin, which blocks fatty acid synthesis and thus leads to 
elevated intracellular malonyl-CoA concentrations. Random mutagenesis of the STS gene 
from Pinus strobus and screening for increased product formation yielded an enzyme variant 
with improved solubility in the heterologous host E. coli. Overall, the combination of 
metabolic engineering strategies and in vivo protein evolution in this study enabled the 
development of an E. coli strain, which produced 70 mg/L pinosylvin from glucose. 
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Additional supplementation of the precursor L-phenylalanine to the medium increased the 
maximum pinosylvin titer to 91 mg/L.  
Other metabolic engineering strategies that were employed, but not mentioned in the 
publication due to limited applicability for our purpose, are the expression optimization of 
the stilbene synthase from Pinus densiflora (PdSTS3) by using the L-arabinose inducible 
promoter system (pBAD) and by constructing an N-terminal translational fusion of the STS to 
the maltose binding protein (MBP) of E. coli. By changing the concentration of L-arabinose 
when using the pBAD system, gene expression levels can be varied and optimized for 
maximum expression of soluble protein (69), while the MBP protein is known for its ability to 
enhance the solubility of the tethered heterologous protein (70). However, soluble 
expression of the PdSTS3 was not improved by either strategy. Furthermore the L-
phenylalanine producing strain E. coli W3110-4(pF20) in short E. coli 4pF20 was used as the 
host strain for improving malonlyl-CoA production and for the episomal expression of the 
pinosylvin operon, as both addition of the amino acid precursor L-phenylalanine and the 
inhibitor of fatty acid biosynthesis cerulenin are still required for improving the microbial 
synthesis of pinosylvin. E. coli 4pF20 is a derivative of E. coli K12 with chromosomal deletions 
Δ(pheA tyrA aroF) and harbors plasmid pF20, which is based on pFJF119EH carrying 
feedback-resistant genes of pheA and aroF (71). A similar strategy as Zha et al. (72) was 
followed for improving the intracellular malonyl-CoA levels, namely overexpression of the 
acetyl CoA-carboxylase (ACC) genes accD1 and accBC from Corynebacterium glutamicum and 
the native acetyl-CoA synthase (ACS), while deleting the competing pathways for acetate 
(ackA-pta operon) and ethanol synthesis (adhE gene). In order to express target genes 
cloned in T7 expression vectors in E. coli 4pF20, the strain was lysogenized with the λDE3 
prophage. While E. coli 4pF20 (DE3) removed the need for L-phenylalanine supplementation 
(similar trans-cinnamic acid levels (approx. 200 mg/L) were measured when feeding 3 mM L-
phenylalanine to E. coli BL21(DE3)), expression of the ACC from C. glutamicum abolished the 
production of pinosylvin. Deletion of the ackA-pta operon and replacement of the adhE gene 
with an additional copy of the acs gene, also did not lead to more acetyl-CoA production as 
could be measured from intracellular samples (Figure 3.1, malonyl-CoA levels were below 
the detection limit). A further strategy that was employed to improve the intracellular 
malonyl-CoA levels was a non-plasmid based method for up-regulating the activity of the 
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ACC from E. coli. Exchanging the native promoter of the accBC operon in the E. coli genome 
with the LacZYA operon promoter, results in isopropyl β-D-1-thiogalactopyranoside (IPTG) 
inducible expression of the biotin carboxyl carrier protein encoded by accB and the biotin 
carboxylase encoded by accC (73). However the promoter exchange did not have a positive 
effect on the pinosylvin titers (malonyl-CoA levels were also below the detection limit). 
 
Figure 3.1: Intracellular acetyl-CoA concentration measured for E. coli strains 4pF20(DE3) and 4pF20 
(DE3, Δyddg, adhE::acs, ΔackA-pta). 
In the second paper ‘’Combinatorial optimization of synthetic operons for the microbial 
production of p-coumaryl alcohol in Escherichia coli’’, the PLICing method was advanced for 
the rapid combinatorial assembly of multiple pathway configurations in E. coli. Subject 
during the development was a four-step pathway enabling E. coli to produce the 
phenylpropanoid p-coumaryl alcohol from the amino acid L-tyrosine. With this method, 81 
different pathway configurations could be individually generated, which differed in the 
length of the spacing between the Shine Dalgarno (SD) sequence and the START codon (5, 9 
or 13 nucleotides) in front of each of the four open reading frames in the synthetic operon. 
An increasing length of this spacing decreased the translation efficiency. Thus, assembly of 
different gene variants to a four-gene operon allowed for balancing of the heterologous 
gene expression in E. coli and resulted in different product titers of individual strains of the 
library. The consequences of the modulation of the translation efficiency were reflected by 
the relative protein amounts in the cells as determined by targeted proteomics applying 
isotope dilution mass spectrometry coupled to high performance liquid chromatography 
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(IDMS-LC-MS/MS). In the course of the experiments the tyrosine ammonia lyase from 
Rhodobacter sphaeroides (RsTAL), catalyzing the first step towards p-coumaryl alcohol 
synthesis, was found to be the limiting enzymatic step of the synthetic pathway. For this 
enzyme the maximum translation efficiency was required for highest p-coumaryl alcohol 
titers (5 nucleotides between the SD sequence and the START codon), whereas medium to 
low translation efficiency in case of the other three enzymes (9 or 13 nucleotides between 
the SD sequence and the START codon) was sufficient. The best strain accumulated 52 mg/L 
p-coumaryl alcohol without any further optimization of cultivation conditions. 
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3.2 
 
Metabolic engineering of Escherichia coli for the synthesis of the 
plant polyphenol pinosylvin 
Philana van Summeren-Wesenhagen and Jan Marienhagen# 
Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH,  
Jülich D-52425, Germany 
 
Plant polyphenols are of great interest for drug discovery and drug 
development since many of these compounds have health promoting activities 
against various diseases such as diabetes, cancer or heart diseases. However, the 
limited availability of polyphenols represents a major obstacle to be overcome 
towards clinical applications. In comparison to isolation from natural sources or 
costly chemical synthesis, the microbial production of these compounds could 
provide sufficient quantities from inexpensive substrates. In this work, we describe 
the development of an Escherichia coli platform strain for the production of 
pinosylvin, a stilbene found in the heartwood of pine trees, which could aid in the 
treatment of various cancers and cardiovascular diseases. Initially, several 
configurations of the three-step biosynthetic pathway to pinosylvin were constructed 
from a set of two different enzymes for each enzymatic step. After optimization of 
gene expression and evaluation of different construct environments, low pinosylvin 
concentrations up to 3 mg/L could be detected. Analysis of precursor supply and a 
comparative analysis of the intracellular pools of pathway intermediates and product 
identified the limited malonyl-CoA availability and low stilbene synthase activity in the 
heterologous host as main bottlenecks during pinosylvin production. Addition of 
cerulenin for increasing intracellular malonyl-CoA pools and in vivo evolution of the 
stilbene synthase from Pinus strobus for an improved activity in E. coli proved to be 
the keys to elevated product titers. These measures allowed product titers of 70 mg/L 
pinosylvin from glucose, which could be further increased to 91 mg/L by the addition 
of L-phenylalanine. 
 
Plant polyphenols are plant secondary 
metabolites, which have important 
functions in plant defense and signaling or 
serve as pigments. Furthermore, many 
polyphenols have anti-oxidant, anti-cancer 
and anti-inflammatory properties, 
rendering these metabolites an invaluable 
source of bioactive compounds for drug 
discovery and drug development in the 
pharmaceutical industry (1).  
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FIG 1  Biosynthetic pathway from L-phenylalanine to pinosylvin. Abbreviations: PAL: 
phenylalanine ammonia lyase, 4CL: 4-coumarate-CoA ligase, STS: stilbene synthase. 
 The polyphenol pinosylvin (trans-
3,5-dihydroxystilbene) is a stilbene, which 
can be predominantly found in the 
heartwood of conifer trees of the genus 
Pinus (2). Pinosylvin protects the plants 
against microbial and fungal decay (3), but 
has also attracted attention due to its 
health benefits for humans. Several recent 
studies indicate a positive effect of 
pinosylvin in the treatment of various 
cancers (4, 5), cardiovascular 
inflammatory diseases (6) and adjuvant 
arthritis (7). Pinosylvin is synthesized from 
the aromatic amino acid L-phenylalanine 
in three enzymatic steps (Fig. 1) (8). L-
phenylalanine is first deaminated to trans-
cinnamic acid by a phenylalanine 
ammonia lyase (PAL, EC 4.3.1.24). The 
resulting acid is subsequently coenzyme A 
(CoA)-activated by a 4-Coumarate-CoA 
ligase (4CL, EC 6.2.1.12) yielding the CoA 
thioester trans-cinnamoyl-CoA. A stilbene 
synthase (STS, EC 2.3.1.146), which is a 
type III polyketide synthase (PKS), 
catalyzes the successive condensation of 
three malonyl-CoA molecules with trans-
cinnamoyl-CoA, forming a linear 
tetraketide intermediate. Finally, the STS 
also cyclizes the tetraketide intermediate 
via an intramolecular C2 → C7 aldol 
condensation to form the stilbene 
pinosylvin (8).  
 The concentration of pinosylvin in 
pine heartwood ranges from 1 – 40 mg/g 
dry weight (including its monomethyl ether) 
(3), rendering the access to pinosylvin 
through extraction difficult. Furthermore, 
purification of pinosylvin from these 
extracts would require the separation from 
a multitude of often structurally very similar 
compounds such as other stilbenes or 
flavonoids (9). Various catalytic and non-
catalytic chemical synthetic routes have 
been devised for the synthesis of 
stilbenes. However these strategies suffer 
from the demand for expensive substrates, 
catalyst instability or degradation or the 
formation of by-products and various 
isomers (10). In contrast, microbial 
production of pinosylvin from glucose 
would have the advantage of being much 
more environmentally friendly compared to 
chemical synthesis, since it avoids the use 
of organic solvents, heavy metals and 
strong acids or bases. To date, several 
microorganisms have been engineered for 
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the microbial stilbene production, 
especially for the synthesis of resveratrol 
(11-13). However, the stilbene production 
with these strains relies on the 
supplementation of phenylpropanoids (e.g. 
coumaric acid or cinnamic acid) as 
stilbene precursors. This strategy has led 
to some considerable success with regard 
to the stilbene resveratrol, where feeding 
of 15 mM p-coumaric acid resulted in 
maximum product titers of 1.4 g/L in E. coli 
(11), which could be further improved to 
1.6 g/L by increasing the carbon flux into 
malonyl-CoA (14). More recently, E. coli 
has been also engineered to produce 35 
mg/L resveratrol from 3 mM of its amino 
acid precursor L-tyrosine (15). This was 
achieved by following a modular metabolic  
 
TABLE 1 Strains and plasmids used in this study. 
Strain or plasmid Relevant characteristics 
Source or 
reference 
Strains 
E. coli DH5α F- ϕ80lacZ∆M15 ∆(lacZYA-argF)U169 recA1 
endA1 hsdR17(rk-, mk+) phoA supE44 thi-1 
gyrA96 relA1 λ- 
Invitrogen 
(Karlsruhe, 
Germany) 
E. coli BL21(DE3) F- ompT hsdSB(rB-, mB-) gal dcm (DE3) Invitrogen 
(Karlsruhe, 
Germany)  
Plasmids 
pCDFDuet1 SptR; 2x T7lac promoters, CDF replicon, lacI, 
His6-tag, S-tag 
Merck Millipore 
(Billerica, MA, 
USA) 
pETDuet1 AmpR; 2x T7lac promoters, ColE1 replicon, lacI, 
His6-tag, S-tag 
Merck Millipore 
(Billerica, MA, 
USA) 
pRSFDuet1 KanR; 2x T7lac promoters, RSF replicon, lacI, 
His6-tag, S-tag 
Merck Millipore 
(Billerica, MA, 
USA) 
pUC18 AmpR; pMB1 replicon, Plac, lacI, the 5’-terminal 
part of the lacZ gene encoding the N-terminal 
fragment of beta-galactosidase   
Merck Millipore 
(Billerica, MA, 
USA) 
pE-Pcpal1 pETDuet1 derivative containing pal-1 from P. 
crispum 
This study 
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pE-Atpal2 pETDuet1 derivative containing pal-2 from A. 
thaliana 
This study 
pC-Pdsts3-Sc4cl pCDFDuet1 derivative containing sts-3 from P. 
densiflora and 4cl A294G from S. coelicolor  
This study 
pC-Pdsts3-At4cl2 pCDFDuet1 derivative containing sts-3 from P. 
densiflora and 4cl-2 N256A/M293P/K320L from A. 
thaliana 
This study 
pC-Pstrsts2-Sc4cl pCDFDuet1 derivative containing sts-2 from P. 
strobus and 4cl A294G from S. coelicolor 
This study 
pC-Pstrsts2-At4cl2 pCDFDuet1 derivative containing sts-2 from P. 
strobus and 4cl-2 N256A/M293P/K320L from A. 
thaliana 
This study 
pR-Pstrsts2 pRSFDuet1 derivative containing sts-2 from P. 
strobus 
This study 
pR-HisPdsts3 pRSFDuet1 derivative containing sts-3 from P. 
densiflora with a N-terminal His6-tag 
This study 
pR-HisPstrsts2 pRSFDuet1 derivative containing sts-2 from P. 
strobus with a N-terminal His6-tag 
This study 
pE-Pcpal1-Sc4cl pETDuet1 derivative containing pal-1 from P. 
crispum and 4cl A294G from S. coelicolor 
This study 
pE-Pcpal1-At4cl2 pETDuet1 derivative containing pal-1 from P. 
crispum and 4cl-2 N256A/M293P/K320L from A. 
thaliana 
This study 
pE-Atpal2-Sc4cl pETDuet1 derivative containing pal-2 from A. 
thaliana and 4cl A294G from S. coelicolor 
This study 
pE-Atpal2-At4cl2 pETDuet1 derivative containing pal-2 and 4cl-2 
N256A/M293P/K320L from A. thaliana 
This study 
pUC18-Pgap-
HisPstrsts2-Sc4cl-
Pcpal1 
pUC18 derivative containing sts-2 from P. strobus 
with a N-terminal His6-tag, 4cl A294G from S. 
coelicolor and pal-1 from P. crispum organized as 
operon under control of the promoter Pgap 
This study 
pR-HisPstrsts2-Sc4cl-
Pcpal1 
pRSFDuet1 derivative containing sts-2 from P. 
strobus with N-terminal His6-tag, 4cl A294G from 
S. coelicolor and pal-1 from P. crispum organized 
as operon 
This study 
pR-T7-accBC-T7-dtsR1 pRSFDuet1 derivative containing accBC and 
dtsR1, encoding the biotin containing α-subunit 
This study 
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and core catalytic  β-subunit, respectively, from 
the acetyl-CoA carboxylase (ACC) of C. 
glutamicum 
pE-fabF pETDuet1 derivative containing β-ketoacyl-acyl 
carrier protein synthase II or FabF from E. coli 
BL21(DE3) 
This study 
pR-HisPstrsts2T248A-
Sc4cl-Pcpal1 
pRSFDuet1 derivative containing sts-2 T248A 
from P. strobus with N-terminal His6-tag, 4cl 
A294G from S. coelicolor and pal-1 from P. 
crispum organized as operon 
This study 
pR-HisPstrsts2Q361R-
Sc4cl-Pcpal1 
pRSFDuet1 derivative containing sts-2 Q361R 
from P. strobus with N-terminal His6-tag, 4cl 
A294G from S. coelicolor and pal-1 from P. 
crispum organized as operon 
This study 
pR-HisPstrsts2T248A/ 
Q361R -Sc4cl-Pcpal1 
pRSFDuet1 derivative containing sts-2 
T248A/Q361R from P. strobus with N-terminal 
His6-tag, 4cl A294G from S. coelicolor and pal-1 
from P. crispum organized as operon 
This study 
 
engineering strategy for balancing the 
pathway with the matB/matC system from 
Rhizobium trifolii, which synthesizes the 
malonyl-CoA precursor from 
supplemented malonate. In comparison, 
reported product titers for pinosylvin are 
modest with 0.6 mg/L achieved with 
Streptomyces venezuelae (when 
supplementing 1.2 mM trans-cinnamic 
acid) (16) and 155 mg/L achieved during 
biotransformation with E. coli (when 
providing 1 mM trans-cinnamic acid and 
augmenting intracellular malonyl-CoA 
levels) (17). 
 In this study, we examined multiple 
genes and pathway configurations for the 
microbial pinosylvin production with E. coli 
from glucose. For this purpose, we 
optimized the heterologous gene 
expression, examined the precursor 
availability and performed laboratory 
protein evolution to enhance the activity of 
a plant-derived STS in the microbial host. 
 
Materials and Methods 
 Bacterial strains, plasmids and 
growth conditions. Bacterial strains and 
plasmids used or constructed in the 
course of this work are listed in Table 1. E. 
coli DH5α, solely used for cloning 
purposes, was routinely cultivated on a 
rotary shaker (170 rpm) at 37°C in LB 
medium or on LB plates (LB medium with 
1.5% [wt/vol] agar) (18). If appropriate, 
carbenicillin (50 µg/mL), kanamycin (30 
µg/mL) or spectinomycin (50 µg/mL) was 
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TABLE 2 Oligonucleotides used in this study. 
Oligonucleotide Sequence (5‘  3‘) and propertiesa 
Cloning of His6-tagged Stilbene synthases 
F_BamHI_PdSTS3 GGATCCAATGGGTGGTGTTGATTTTGAAGGTTTTCG (BamHI) 
R_NotI_PdSTS3 GCGGCCGCTTATTACGGATGACAGGTAC (NotI) 
F_BamHI_PstrSTS2 GGATCCAATGGGAAGCGTTGGTATGGGTG (BamHI) 
R_NotI_PstrSTS2 GCGGCCGCTTATTACGGAAACGGAATGC (NotI) 
Construction of the pinosylvin operon under control of the T7 promoter 
F_Sc4CL_NotI CGCAGTGCGGCCGCGAAAGGAGGTCTATATGTTTCGTAGCGA
ATATGC (NotI) 
R_Sc4CL CGCAGTGGTACCCGCATAGTACTTTATTAACGCGGTTCACGCA
G (KpnI/ScaI) 
F_PcPAL1 CGCAGTGGTACCGAAAGGAGGTCTATATGGAAAATGGTAATG
GTGCAAC (KpnI) 
R_PcPAL1_XhoI CGCAGTCTCGAGTTATTAACAAATCGGCAGCGGTGCACCATTC
CAG (XhoI) 
Construction of the pinosylvin operon under control of the Pgapdh promoter 
F_Pgapdh_NdeI CGCCATATGGATCAAACAGTGATATACGCCGTCAC (NdeI) 
R_Pgapdh_HindIII CGCAAGCTTATATTCCACCAGCTATTTGTTAGTGAATAAAAGG 
(HindIII) 
F_HisPstrSTS2_SalI CGCAGTGTCGACAAGGAGATATACCATGGGCAGCAGCCATCA
CCATC (SalI) 
R_HisPstrSTS2_NheI CGCATGCTAGCTTATTACGGAAACGGAATGCTTTTCAGCACAA
C (NheI) 
F_Sc4CL CGCAGTGGATCCGAAAGGAGGTCTATATGTTTCGTAGCGAATA
TGCAG (BamHI) 
R_Sc4CL CGCAGTGGTACCCGCATAGTACTTTATTAACGCGGTTCACGCA
G (KpnI/ScaI) 
F_PcPAL1 CGCAGTGGTACCGAAAGGAGGTCTATATGGAAAATGGTAATG
GTGCAAC (KpnI) 
R_PcPAL1 CGCAGTGAATTCTTATTAACAAATCGGCAGCGGTG (EcoRI) 
Construction of pR-T7-accBC-T7-dtsR1 
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a Recognition sites for the indicated restriction enzymes are underlined.
 
added to the medium. Growth was 
determined by measuring the optical 
density at 600 nm (OD600).  
 Recombinant DNA techniques. 
The enzymes for recombinant DNA work 
were obtained from Thermo Scientific 
(Waltham, MA, USA) and Merck Millipore 
(Billerica, MA, USA). Routine methods like 
PCR, restriction, or ligation were carried 
out according to standard protocols (18). 
Oligonucleotides used for cloning, error 
prone PCR (epPCR) and site directed 
mutagenesis (19) were obtained from 
Eurofins Genomics (Ebersberg, Germany) 
and are listed in Table 2. E. coli was 
transformed by the RbCl method (20). The 
PAL, 4CL and STS genes were chemically 
synthesized by GeneArt Gene Synthesis 
services from Life Technologies, a Thermo 
Fisher Scientific company (Waltham, MA, 
USA). Genes were codon optimized for 
expression in E. coli employing the 
proprietary GeneOptimizer software. For 
subcloning purposes, all PAL and STS 
genes were synthesized with a 5’-NcoI 
and a 3’-BamHI restriction site, whereas 
the synthetic 4CL genes incorporate a 5’-
NdeI site and a 3’-XhoI site. The 5’-NdeI 
F_accBC_BamHI CGCAGTGGATCCTGTCAGTCGAGACTAGGAAGATCACCAAG 
(BamHI) 
R_accBC_HindIII CGCAGTAAGCTTTTATTACTTGATCTCGAGGAGAACAACGC 
(HindIII) 
F_dtsR1_NdeI CGCAGTCATATGATGACCATTTCCTCACCTTTGATTGACGTCG
CCAACC (NdeI) 
R_dtsR1_XhoI CGCAGTCTCGAGTTATTACAGTGGCATGTTGCCGTGCTTG 
(XhoI) 
Construction of pE-fabF 
F_fabF_NcoI CGCAGTCCATGGGTGTCTAAGCGTCGTGTAGTTGTG (NcoI) 
R_fabF_EcoRI CGCAGTGAATTCGCAGCATGTTCACTACGGAACAAGTC 
(EcoRI) 
PstrSTS3 error prone PCR 
F_PstrSTS2_Ep CGCAGTGGATCCAATGGGAAGCGTTGGTATGGGTG (BamHI) 
R_PstrSTS2_Ep CGCAGTGCGGCCGCTTATTACGGAAACGGAATGC (NotI) 
Site directed mutagenesis at Q361 of  PstrSTS3 
F_Q361R CGTAAAGCAAGCCGTCGGAATGGTTGTAGCACC 
R_Q361R GGTGCTACAACCATTCCGACGGCTTGCTTTACG 
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and 5’-NcoI restriction sites already 
include the START-codon ATG as part of 
their recognition site. However, in case of 
the sts-2 gene from P. strobus, subcloning 
using the NcoI site required the addition of 
the glycine codon GGA after the START-
codon since the NcoI-recognition site (5’-
CCATGG-3’) comprises a G following the 
START-ATG codon.  
 Heterologous gene expression. 
Recombinant E. coli BL21(DE3) strains 
expressing genes for the pinosylvin 
synthetic pathway were cultivated in 25 
mL LB medium in 100 mL baffled shake 
flasks at 37°C and 120 rpm until an OD600 
of 0.6 was reached. After induction with 1 
mM isopropyl-β-D-thiogalactopyranoside 
(IPTG) the cultivation continued at 30°C 
for 24 hours. Cells were then harvested by 
centrifugation (3,900 g; 15 min; 4°C) and 
washed with 5 mL 0.9 wt% NaCl solution. 
After centrifugation (3,900 g; 15 min; 4°C) 
the cells were resuspended in 1 mL 
phosphate-buffered saline (1.9 mM 
NaH2PO4; 8.1 mM Na2HPO4; 154 mM 
NaCl; pH 7.4) and disrupted by sonication 
using a Branson Sonifier 250 (intensity 2; 
duty cycle 20%; 4 min; Branson, Danbury, 
CT, USA). After removal of the cellular 
debris by centrifugation (16,000 g; 30 min; 
4°C), the cell free extract (CFE) was 
subjected to SDS-PAGE analysis using 
NuPAGE Bis-Tris gels from Life 
Technologies (Waltham, MA, USA).  
 For the purification of the His6-
tagged STS proteins, E. coli BL21(DE3) 
cultures were cultivated in 100 mL LB 
medium in 500 mL baffled shake flasks on 
a rotary shaker (120 rpm) at 37°C until 
reaching an OD600 of 0.2. The cultures 
were shifted to 30°C and gene expression 
was induced with 0.1 mM IPTG as soon as 
an OD600 of 0.6 was reached. After four 
hours the cells were harvested by 
centrifugation (6,200 g; 10 min; 4°C) and 
washed with an ice cold 0.9 wt% NaCl 
solution. After centrifugation (6,200 g; 10 
min; 4°C),  the cells were resuspended in 
1 mL NNI10 lysis buffer (50 mM NaH2PO4; 
300 mM NaCl; 10 mM imidazole; pH 8) 
and subsequently disrupted by sonication 
(intensity 2; duty cycle 20%; 4 min). The 
resulting CFE was clarified by 
centrifugation (16,000 g; 30 min; 4°C). A 
column volume of 1 mL nickel-
nitrilotriacetic acid resin (Qiagen, Hilden, 
Germany) was used for the protein 
purification. After equilibration of the 
column by applying five column volumes 
(CV) of NNI10 buffer, the CFE was loaded 
on the column. Subsequently, the column 
was washed three times with 10 CV of 
NNI70 wash buffer (50 mM NaH2PO4; 300 
mM NaCl; 70 mM imidazole; pH 8). The 
elution of the STS proteins was achieved 
by applying six times one CV of NNI250 
elution buffer (50 mM NaH2PO4; 300 mM 
NaCl; 250 mM imidazole; pH 8). The 
eluted fractions were judged by SDS-
PAGE analysis.  
 Furthermore, the successful 
expression of all PAL, 4CL and HisSTS 
proteins was verified by MALDI-ToF-MS 
as previously described (21).  
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 Pinosylvin production with E. 
coli. Recombinant E. coli BL21(DE3) 
strains were either cultivated in 50 mL LB 
broth or in 50 mL Yeast Nitrogen Base 
(YNB) defined medium in 500 mL baffled 
shake flasks on a rotary shaker (120 rpm) 
at 26°C. For the preparation of 1 L YNB 
medium 100 mL of 10 times concentrated 
YNB was added to 900 mL base medium 
(6 g K2HPO4; 3 g KH2PO4; 10 g 3-(N-
Morpholino)propanesulfonic acid (MOPS); 
pH 7) and 5 g/L glucose was added as 
carbon source. Precultures were cultivated 
overnight at 37°C (170 rpm) in LB or YNB 
medium, then diluted to an OD600 of 0.1 in 
50 mL fresh LB or YNB medium, 
respectively. When the OD600 of these 
main cultures reached 0.6, gene 
expression was induced with 1 mM IPTG 
(when necessary) and the cultivation was 
continued for 36 hours at 26°C. Samples 
were taken at regular time intervals for LC-
MS analysis to follow the formation of 
pinosylvin.   
 A two-stage cultivation procedure 
was also employed for pinosylvin 
production. In the first stage, cultivation 
and gene expression were performed in 
LB as described above. After 5 hours of 
heterologous gene expression, cells were 
collected by centrifugation (4,300 g; 15 
min; 4°C) and subsequently resuspended 
in 10 mL YNB medium 5 g/L glucose and 
supplemented with 1 mM IPTG. The 
cultivation of this second phase was 
continued for 36 hours at 26°C. Again, 
samples were taken at regular time 
intervals for LC-MS analysis. 
 Metabolite extraction. Metabolite 
extracts from supernatant and cells were 
prepared for LC-MS analysis by mixing 1 
mL culture with 1 mL ethyl acetate and 
vigorous shaking (1,400 rpm; 10 min; 
20°C) in an Eppendorf thermomixer 
(Hamburg, Germany). 800 µl of this 
suspension were centrifuged for five 
minutes at 16,000 g and the ethyl acetate 
layer was transferred to an organic solvent 
resistant deep-well plate (Eppendorf, 
Hamburg, Germany). After evaporation of 
the ethyl acetate, 100 µl acetonitrile, 
concentrating the extract eight-fold, were 
added prior to LC-MS analysis.   
 Determination of cytoplasmic 
metabolite concentrations.  E. coli cells 
were separated from the medium and 
inactivated by silicone oil centrifugation for 
the determination of cytoplasmic 
concentrations of trans-cinnamic acid, 
trans-cinnamoyl CoA, malonyl-CoA and 
pinosylvin as described previously (22). 
The resulting upper-phase was used for 
further analysis by LC-MS/MS.  
 Chemical synthesis of trans-
cinnamoyl-CoA. trans-cinnamic acid was 
esterified in the presence of CoA and 
dicyclohexyl carbodiimide as previously 
described to prepare a standard for the 
LC-MS/MS analysis of trans-cinnamoyl-
CoA (23). All required chemicals were 
purchased from Sigma-Aldrich (St. Louis, 
MO, USA).  
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 Determination intermediates and 
pinosylvin by LC-MS and LC-MS/MS. 
trans-cinnamic acid and pinosylvin in cell-
free culture medium as well as in the ethyl 
acetate extracted samples were quantified 
by LC-MS using an ultra-high-performance 
LC (uHPLC) 1290 Infinity system coupled 
to a 6130 Quadrupol LC-MS system 
(Agilent, Santa Clara, CA, USA). LC 
separation was carried out with a kinetex 
1.7u C18 100A column (50 mm x 2.1 mm 
internal diameter; Phenomenex, Torrance, 
CA, USA) at 50°C. For elution, 0.1% acetic 
acid (solvent A) and acetonitrile 
supplemented with 0.1% acetic acid 
(solvent B) were applied as the mobile 
phases at a flow rate of 0.5 mL/min. A 
gradient was used, where solvent B was 
stepwise increased (minute 0 – 1: 15% to 
22%; minute 1 – 2: 22% to 40%; minute 2 
– 2.5: 40% to 50%; minute 2.5 – 3: 50% to 
100%). The mass spectrometer was 
operated in the negative electrospray 
ionization (ESI) mode and data acquisition 
was performed in selected-ion-monitoring 
mode. LC-MS/MS was used for the 
quantification of trans-cinnamic acid, trans-
cinnamoyl-CoA, malonyl-CoA and 
pinosylvin in the cytoplasmic extracts 
following a previously described method 
(24). Trans-cinnamic acid, malonyl-CoA 
and pinosylvin standards were purchased 
from Sigma-Aldrich (St. Louis, MO, USA). 
 Construction of Pstrsts-2 epPCR 
libraries and microtiter plate screening 
for increased pinosylvin production. All 
epPCRs of the sts-2 gene from P. strobus, 
with mutation rates varying from 2 - 4.6 
mutations/kb, were performed using the 
Diversify PCR Random Mutagenesis Kit 
from Clontech (Mountain View, CA, USA).  
The mutated Pstrsts2 genes were sub-
cloned into the pRSFduet1 backbone 
carrying the genes for the PcPAL1 and the 
Sc4CL, (resulting in the vector pR-
HisPstrsts2*-Sc4cl-Pcpal1) and 
transformed to E. coli BL21(DE3). At least 
90 clones for each mutation rate, always 
accompanied by a negative control (E. coli 
BL21(DE3) pRSFDuet1) and a strain 
expressing the wild type sts-2 gene (E. coli 
BL21(DE3) pR-HisPstrsts2-Sc4cl-Pcpal1) 
were screened for improved pinosylvin 
titers. For this purpose cultivation and 
screening were performed in the 96-well 
microtiter plate format. The libraries were 
cultivated in 600 µl YNB medium 
supplemented with 5 g/L glucose, 3 mM L-
phenylalanine, 0.5 mM IPTG and 30 
µg/mL kanamycin in deep-well plates from 
Eppendorf (Hamburg, Germany) in a 
microtron shaker from Infors (Bottmingen, 
Switzerland) at 30°C, 900 rpm and 75% 
humidity for 24 hours. Subsequently, 100 
µl culture of each well was transferred to a 
UV transparent 96 well flat bottom plate 
from Corning (Corning, NY, USA). An 
Infinite M200 PRO microplate reader 
(Tecan, Männedorf, Switzerland) was used 
to relatively compare pinosylvin titers 
based on the fluorescent properties of 
pinosylvin (λex: 316 nm; λem: 388 nm). 
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Results 
 Design of a synthetic pathway 
for pinosylvin. For the construction of a 
synthetic pinosylvin pathway we first 
consulted recent literature and the 
BRaunschweig ENzyme DAtabase 
(BRENDA) to identify suitable 
phenylalanine ammonia lyases (PALs), 4-
coumarate-CoA ligases (4CLs) and 
stilbene synthases (STSs) originating 
either from plants or microorganisms (25). 
Enzymes were considered as suitable if 
they had been already functionally 
expressed in E. coli and if the determined 
basic catalytic parameters (e.g. kcat, Km) 
appeared to be promising for the 
construction of an efficient biosynthetic 
route towards pinosylvin. In the course of 
that survey, we selected the PAL isozyme 
1 from Petroselinum crispum (PcPAL1) 
and the PAL isozyme 2 from Arabidopsis 
thaliana (AtPAL2) since both enzymes are 
characterized by a high activity when 
expressed in E. coli. Furthermore, we 
decided to express a variant of a 4CL-like 
enzyme (Sc4CL) from the gram-positive 
bacterium Streptomyces coelicolor, which 
favors trans-cinnamic acid over p-
coumaric acid as substrate and a variant 
of the 4CL isozyme 2 of Arabidopsis 
thaliana (At4CL2). As candidates for 
stilbene synthases we selected the STS 
isozyme 3 of Pinus densiflora (PdSTS3) 
and STS isozyme 2 of Pinus strobus 
(PstrSTS2) as these isozymes were 
reported to have a high specificity and 
activity towards cinnamoyl-CoA. 
 Optimization of the heterologous 
gene expression. For initial gene 
expression experiments, all PAL genes 
were cloned into the pETDuet1-vector, 
whereas the STS- and 4CL-genes were 
cloned into pCDFduet1-vector under the 
individual control of a T7-promoter. The 
successful expression of soluble protein 
could be verified for all PALs and 4CLs by 
SDS-PAGE analysis. However, no visible 
bands indicating successful expression of 
PdSTS3 or PstrSTS2, could be observed 
in the soluble or the insoluble protein 
fractions (data not shown). Neither 
incremental reduction of the expression 
temperature from 30°C to 15°C, nor 
variation of the IPTG concentration (0.4 
mM to 1 mM) improved STS expression. 
Furthermore, a first analysis of the 
supernatant of the expression cultures 
showed that up to 1.7 mM trans-cinnamic 
acid, but no pinosylvin was produced by 
the recombinant E. coli strains. In order to 
improve the expression of PdSTS3 and 
PstrSTS2, both genes were individually 
cloned into the pRSFDuet1 vector, another 
member of the pDuet vector family, with 
the RSF origin of replication allowing for 
higher copy numbers of the plasmids per 
cell (>100 copies per cell). In addition, 
both genes were cloned with a N-terminal 
His6-tag, since such a tag improved the 
soluble expression of PdSTS3 without 
affecting the activity of the STS in in vitro 
enzyme assays (26). Despite these 
alterations, no soluble STS expression 
was observable in CFEs, but both His6-
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tagged enzymes (HisPstrSTS2 and 
HisPdSTS3) could be identified in the 
whole cell fraction. Purification of the 
enzymes from the CFE by affinity 
chromatography finally revealed low 
expression of soluble HisPstrSTS2 protein 
but not HisPdSTS3 in the CFE (Figure S1, 
supplemental material). Possibly, native E. 
coli proteins concealed the band 
corresponding to HisPstrSTS2 on the 
SDS-PAGE-analysis of the CFE. Finally, 
the identity of all PALs, 4CLs and HisSTS 
proteins was confirmed by MALDI-ToF-MS 
(data not shown). Accompanying chemical 
analysis of the cultures during the 
optimization of heterologous gene 
expression revealed that the modification 
of STS-expression already resulted in the 
accumulation of low concentrations of 
pinosylvin (0.068 ± 0.004 mg/L), but only 
in extracts of strains expressing the 
HisSTS of P. strobus.  
 Identification of the most 
suitable pathway configuration. After 
the identification of His6-tagged PstrSTS2 
as the only functional STS in E. coli, four 
different synthetic pathways with all 
combinations of the available PALs and 
4CLs were constructed. Subsequently, 
pinosylvin production of all four strains 
was compared using the two-phase 
cultivation conditions as described in 
materials and methods. As it turned out, 
combination of the PAL from P. crispum, 
the 4CL from S. coelicolor and the STS 
from P. strobus proved to be the most 
productive pathway variant, but only a low 
product concentration of up to 0.64 mg/L 
pinosylvin could be detected (Table 3). 
Interestingly, the combination of PcPAL1 
and At4CL2 did not lead to any detectable 
product formation although both enzymes 
functioned in other pathway 
configurations.  The positive effect of the 
His6-tag on PstrSTS2 expression was also 
reflected by increased pinosylvin titers as 
the same strain expressing PstrSTS2 
without the His6-tag, accumulated only up 
to 0.22 mg/L pinosylvin (Table 3).  
 At this point, all genes of the 
pinosylvin pathway were expressed under 
control of their own T7 promoter to rule out 
any polar expression effects. With the aim 
to evaluate the expression of the pathway 
from a single three-gene operon, two 
additional plasmids were constructed, in 
which the operon was either expressed 
under the control of the IPTG inducible T7 
promoter (using the pRSFDuet1 vector 
backbone), or the constitutive gap 
promoter (Pgap) of the glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) from 
E. coli (using the pUC18 vector backbone) 
(27). The gap promoter was selected, as it 
induces gene expression during cultivation 
on glucose as carbon source, thus 
allowing the continuous transcription of the 
three heterologous genes. Surprisingly, no 
pinosylvin formation could be detected 
when the synthetic operon was 
constitutively expressed during single 
phase cultivation in YNB supplemented 
with 5 g/L glucose. Only the accumulation 
of up to 10 mg/L trans-cinnamic acid 
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during the cultivation could be measured. 
In contrast, IPTG-induced expression from 
the T7 promoter of the tricistronic 
pRSFDuet1-construct led to a six fold 
increased pinosylvin titer with E. coli 
BL21(DE3) pR-HisPstrsts2-Sc4cl-Pcpal1 
(up to 3.37 mg/L), when compared to the 
monocistronic organization of the same 
genes in E. coli BL21(DE3) pE-Pcpal1-
Sc4cl pR-HisPstrsts2 (Table 3).  
 Availability of precursors and 
intermediates during pinosylvin 
synthesis. At this stage, insufficient levels 
of the precursors L-phenylalanine and 
malonyl-CoA could be limiting for the 
overall product titers. In order to find out 
whether the availability of L-phenylalanine 
or malonyl-CoA were limiting, cultivations 
were performed in which 3 mM L-
phenylalanine and/or cerulenin (up to 200 
µM) were supplemented during the 
production phase (Fig. 2). Cerulenin is an 
antifungal antibiotic produced by 
Cephalosporium caerulens, which blocks 
fatty acid biosynthesis by inhibiting the β-
ketoacyl-acyl carrier protein synthases 
FabB and FabF, thereby preventing 
channeling of malonyl-CoA into the 
pathway for fatty acid synthesis (28). The 
exclusive supplementation of L-
phenylalanine had no positive effect on the 
pinosylvin production (3.29 ± 0.11 mg/L 
without supplementation vs. 3.49 ± 0.42 
mg/L with supplementation), but resulted 
in the accumulation of the intermediate 
trans-cinnamic acid in the supernatant 
(data not shown). In contrast, addition of 
cerulenin drastically increased product 
titers up to 18-fold, reaching 59 mg/L 
pinosylvin at a concentration of 200 µM 
cerulenin (and no addition of L-
phenylalanine).  
 Subsequently, cytoplasmic levels of 
malonyl-CoA in E. coli BL21(DE3) were 
determined to verify that the addition of 
cerulenin had an effect on the intracellular 
malonyl-CoA pool. These experiments 
revealed, that the intracellular malonyl-
CoA level increased from 2 pmol/mg CDW 
(no cerulenin) to 105 pmol/mg CDW 1.5 
hours after the addition of 200 µM 
cerulenin. In contrast, E. coli BL21(DE3) 
pR-HisPstrsts2-Sc4cl-Pcpal1 accumulates 
malonyl-CoA only up to 59 pmol/mg CDW 
in the presence of 200 µM cerulenin and  
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TABLE 3 Pinosylvin production with E. coli strains harboring different variants of the 
pinosylvin pathway in mono- or tricistronic transcriptional units. 
Strain 
Pinosylvin titer  
(mg/L) 
experiment 1 
Pinosylvin titer 
(mg/L) 
experiment 2 
E. coli BL21(DE3) pE-Pcpal1-Sc4cl pR-HisPstrsts2 0.49 0.64 
E. coli BL21(DE3) pE-Pcpal1-At4cl2 pR-HisPstrsts2 —a —a 
E. coli BL21(DE3) pE-Pcpal1-Sc4cl pR-Pstrsts2 0.21  0.22 
E. coli BL21(DE3) pE-Atpal2-Sc4cl pR-HisPstrsts2 0.27 0.36 
E. coli BL21(DE3) pE-Atpal2-At4cl2 pR-HisPstrsts2 0.24 0.31 
E. coli BL21(DE3) pUC18-Pgap-HisPstrsts2-Sc4cl-
Pcpal1 
—
a
 —
a
 
E. coli BL21(DE3) pR-HisPstrsts2-Sc4cl-Pcpal1 3.21 3.37 
a Below limit of detection 
during pinosylvin synthesis (Figure S2, 
supplemental material), indicating malonyl-
CoA consumption during pinosylvin 
formation. 
 
FIG 2 Pinosylvin production of E. coli 
BL21(DE3) pR-HisPstrsts2-Sc4cl-Pcpal1 
with and without supplementation of L-
phenylalanine and/or addition of cerulenin. 
The experiments were performed in 
triplicate.  
 
 L-phenylalanine supplementation had a 
positive impact on product formation 
during cerulenin-mediated inhibition of the 
fatty acid synthesis, indicating that the 
availability of this precursor becomes 
limiting when more malonyl-CoA is 
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available (Fig. 2). At this stage, 
supplementation of 3 mM L-phenylalanine 
and addition of 200 µM of cerulenin led to 
the highest pinosylvin titers of 70 mg/L 
after 36 hours of cultivation. 
 Two additional strategies were 
pursued for improving the intracellular 
malonyl-CoA availability in E. coli to 
circumvent cerulenin addition: 
Overexpression of the intrinsic β-ketoacyl-
acyl carrier protein (ACP) synthase II 
(FabF) for reducing the drain of malonyl-
CoA into fatty acid synthesis, as well as 
heterologous expression of the acetyl-CoA 
carboxylase from Corynebacterium 
glutamicum (ACC) for increasing the 
intracellular generation of malonyl-CoA 
from acetyl-CoA. Unfortunately 
heterologous expression of either enzyme 
only led to reduced pinosylvin titers (data 
not shown). 
 The availability of the intermediate 
trans-cinnamoyl-CoA could also be limiting 
during pinosylvin synthesis due to low 
4CL-activity. Therefore, the relative 
intracellular levels of trans-cinnamic acid, 
trans-cinnamoyl-CoA and pinosylvin were 
determined during cultivation with 3 mM L-
phenylalanine and with and without 
addition of cerulenin in the production 
phase (Fig. 3). During these experiments, 
L-phenylalanine was always 
supplemented to ensure that trans-
cinnamic acid as direct precursor of trans-
cinnamoyl-CoA is not limiting in the 
presence of cerulenin. All measurements 
were conducted two hours after addition of 
cerulenin, but only relative levels of 
intermediates and product could be 
determined, since no trans-cinnamoyl-CoA 
standard of sufficient purity could be 
chemically synthesized. As a result, 
addition of 200 µM of cerulenin led to an 
18-fold increase of pinosylvin, 
accompanied by a drop of the trans-
cinnamoyl-CoA level of only 30%. This 
observation hints at sufficient levels of 
trans-cinnamoyl-CoA to achieve higher 
product titers as the pool of this 
intermediate is not depleted or even 
significantly reduced. 
 
FIG 3 Relative intracellular levels of trans-
cinnamic acid, trans-cinnamoyl-CoA and 
pinosylvin as determined by LC-MS/MS. 
The experiments with E. coli BL21(DE3) 
pR-HisPstrsts2-Sc4cl-Pcpal1 were 
performed in duplicate with 
supplementation of 3 mM L-phenylalanine 
and 0 µM or 200 µM cerulenin. The 
relative levels are given in “Area %” with 
the intermediates determined at 0 µM 
cerulenin set to 100%.  
  Directed protein evolution of 
HisPstrSTS2. The PAL- and 4CL-activity 
in E. coli appears to be sufficient to 
 -46- RESULTS            Microbial pinosylvin production 
support higher product titers as the 
intracellular pools of trans-cinnamic acid 
and trans-cinnamoyl-CoA are not depleted 
during pinosylvin production. In contrast, 
expression of the STS was still low 
although the gene sequences of all STS 
genes were optimized for an expression in 
E. coli prior to gene synthesis. Hence, the 
poor soluble expression of HisPstrSTS2 in 
the microbial host might be limiting the 
performance of the pinosylvin pathway. 
With the aim to adapt the STS2 of P. 
strobus for an optimal expression in E. 
coli, we performed directed evolution of 
the HisPstrSTS2 in vivo. For this purpose 
we randomly mutated the codon optimized 
open reading frame of HisPstrsts2 by 
epPCR and subcloned the resulting STS-
library into pR-Sc4cl-Pcpal to complete the 
pinosylvin pathway. Cultivation and 
screening of the library was performed in 
the MTP-format, taking advantage of the 
fluorescence of pinosylvin for identifying 
clones with increased product titers in 
comparison to the starting strain E. coli 
BL21(DE3) pR-HisPstrsts2-Sc4cl-Pcpal1. 
Screening of 450 clones yielded two 
clones exhibiting a higher fluorescence 
under screening conditions. DNA 
sequencing revealed that each STS gene 
carries a single point mutation (A742G and 
A1082G), both leading to amino acid 
substitutions (T248A and Q361R, 
respectively). After recloning of the STS 
variants and retransformation to exclude 
any effect of the plasmid or strain 
background, the product titers of both 
variants were compared to the starting 
strain using the optimized cultivation 
conditions with and without the addition of 
cerulenin or the supplementation of L-
phenylalanine.  
Under all cultivation conditions tested, 
both amino substitutions in HisPstrSTS2 
individually improved the overall product 
titers (Fig. 4). In a direct comparison, the 
positive effect of T248A for the pinosylvin 
formation was more pronounced as more 
pinosylvin could be detected in the 
extracts. In the presence of cerulenin, but 
without supplementation of L-
phenylalanine, 70 mg/L pinosylvin 
accumulated in the E. coli BL21(DE3) pR-
HisPstrsts2T248A-Sc4cl-Pcpal1 cultures, 
whereas an additional supplementation of 
3 mM L-phenylalanine increased the 
pinosylvin titer to 91 mg/L. However, the 
combination of both amino acid 
substitutions in an attempt to further boost 
product formation failed and most likely 
resulted in an inactive STS variant as no 
pinosylvin synthesis of E. coli BL21(DE3) 
pR-HisPstrsts2T248A/Q361R-Sc4cl-
Pcpal1 was detected. 
 
FIG 4 Comparison of the pinosylvin titers 
of E. coli BL21(DE3) pR-HisPstrsts2-
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Sc4cl-Pcpal1 expressing either 
HisPstrsts2-wt (light grey), HisPstrsts2-
Q361R (dark grey) or HisPstrsts2-T248A 
(black) without any supplementation, 
addition of 200 µM cerulenin or addition of 
200 µM cerulenin and supplementation of 
3 mM L-phenylalanine. The experiments 
were performed in duplicate.  
 
Discussion 
 The development of efficient 
microbial platform organisms for the 
production of (plant) natural products 
requires the identification of suitable 
enzymes, the design of stable genetic 
constructs for gene expression and the 
optimal adaptation of the synthetic 
pathway to the host cell metabolism (or 
vice versa). In this work, we systematically 
explored several strategies to engineer E. 
coli towards the microbial production of the 
stilbene pinosylvin. The efforts included 
the optimization of gene expression 
conditions, the comparison of different 
expression constructs and protein 
engineering to adapt the expression of the 
plant-derived STS2 from P. strobus to the 
microbial host system.  
Since construction of stilbene 
producing microorganisms has been 
mostly limited to strains requiring the 
supplementation of phenylpropanoid 
intermediates, we decided to design and 
implement the complete three-step 
pathway to pinosylvin starting from the 
amino acid L-phenylalanine. We set off 
with the identification of the most suitable 
enzymes from various microbial or plant 
sources in literature and databases, and 
selected two enzymes for each of the 
three required enzymatic steps based on 
their kinetic properties. PALs, catalyzing 
the first committed step towards 
phenylpropanoid synthesis, can be found 
in all higher plants, but are also present in 
yeast, fungi and some prokaryotic species 
(29). The PAL isozyme 1 from 
Petroselinum crispum (PcPAL1) and the 
PAL isozyme 2 from Arabidopsis thaliana 
(AtPAL2) were selected for the 
construction of the pinosylvin pathway 
since both enzymes are characterized by 
a high activity when expressed in E. coli 
(30, 31). In comparison to PALs, 4CLs are 
specific to the secondary metabolism of 
plants. Most 4CLs described, are 
substrate specific since all described 
natural substrates are characterized by a 
4´-hydroxyl group on the phenyl ring (32). 
However, a synthetic pathway leading to 
pinosylvin requires a CoA-ligase that 
accepts trans-cinnamic acid lacking this 
para-hydroxy moiety. Interestingly, Kaneko 
and coworkers discovered a bacterial 4CL-
like enzyme from the filamentous, soil-
dwelling, gram-positive bacterium 
Streptomyces coelicolor (33). The enzyme 
showed a distinct 4CL activity, favoring 
trans-cinnamic acid over p-coumaric acid 
as substrate. Mutational analysis of the 
substrate binding pocket identified the 
amino acid substitution A294G conferring 
an even higher catalytic activity towards 
trans-cinnamic acid compared to the 
 -48- RESULTS            Microbial pinosylvin production 
native enzyme. This particular enzyme 
variant (Sc4CL) was selected for an 
evaluation in the synthetic pinosylvin 
pathway. The second 4CL candidate was 
a variant of the 4CL isozyme 2 of 
Arabidopsis thaliana (At4CL2) bearing 
three amino acid substitutions (N256A, 
M293P, K320L). In in vitro enzyme assays, 
this mutein demonstrated a 30-fold higher 
conversion of trans-cinnamic acid 
compared to the native enzyme (34). 
Pinosylvin-forming stilbene synthases (EC 
2.3.1.146), are typical for gymnosperms 
and to date several such enzymes have 
been identified in three pine species 
(Pinus sylvestris (35), Pinus densiflora (26) 
and Pinus strobus (36)). STS isozyme 3 of 
P. densiflora (PdSTS3) and STS isozyme 
2 of P. strobus (PstrSTS2) were selected 
as STS candidates, as these isozymes 
were reported to have higher specificity 
and activity towards cinnamoyl-CoA in 
comparison to the other isozymes in in 
vitro enzyme assays (26, 36). Interestingly, 
compared to other characterized STSs, 
PdSTS3 has a truncated C-terminus, 
which is believed to be responsible for the 
observed release from feedback inhibition 
by pinosylvin (26).  
The combination of PcPAL1 and 
Sc4CL in the synthetic pinosylvin pathway 
turned out to be more beneficial for high 
product titers than the combination of 
AtPAL2 and Sc4CL. This is interesting 
because the At4CL2 performed better with 
the AtPAL2 than with the PAL from P. 
crispum. This could be simply due to the 
common origin of both enzymes from A. 
thaliana but also supports the notion that 
the performance of an entire synthetic 
pathway should be evaluated instead of 
just assembling a pathway from 
individually characterized “best parts”. 
Pinosylvin production could be improved 
by organizing the three genes of the final 
pinosylvin pathway configuration in an 
operon under the control of a single 
promoter. This same effect was also 
observed during the development of a 
microbial production strain for resveratrol, 
where cotranscription of the genes for 
4CLs and STSs was believed to lead to a 
more balanced gene expression (11). 
 The malonyl-CoA availability turned 
out to be crucial for the overall product 
titers as the addition of the fatty acid 
production inhibitor cerulenin boosted the 
pinosylvin titers 18 to 20-fold, whereas the 
supplementation of L-phenylalanine alone 
had no effect. In order to avoid the 
addition of cerulenin, two strategies for 
increasing the intracellular malonyl-CoA 
availability were followed: overexpression 
of E. coli´s own FabF (37) as well as 
heterologous expression of the ACC from 
C. glutamicum as it was successfully 
demonstrated during microbial polyketide 
synthesis and flavanone synthesis, 
respectively (17, 38, 39). However, none 
of these approaches had the desired effect 
as the pinosylvin production significantly 
decreased or ceased entirely. No 
improvement of the microbial flavonoid 
production was also observed during 
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microbial flavonoid production with E. coli 
upon expression of the ACC from C. 
glutamicum, suggesting that this strategy 
is not generally applicable (40). A 
comparative analysis of intracellular 
intermediate availability and product 
concentration in the presence or absence 
of 200 µM cerulenin was conducted, but 
the obtained results did not reveal a 
limiting enzymatic step when more 
malonyl-CoA is available. Additional 
experiments will be necessary to shed 
more light on this subject. 
 Finally, we performed directed 
protein evolution to adapt the expression 
of the pine-derived HisPstrSTS2 to the 
microbial host system. This was directly 
done in the genetic context of the 
pinosylvin pathway. Only one round of 
diversity generation by epPCR and MTP-
based screening of 450 clones for 
increased pinosylvin-related fluorescence 
identified two clones with improved 
product formation, each bearing a single 
amino acid substitution. The combination 
of both mutations had a detrimental effect 
on product formation, but the T248A 
substitution alone increased the final 
pinosylvin titer of the best strain E. coli 
BL21(DE3) pR-HisPstrsts2-Sc4cl-Pcpal1 
from 59 mg/L to 70 mg/L in the presence 
of 200 µM cerulenin, and by an additional 
30% to 91 mg/L when L-phenylalanine 
was also supplemented. With the aim to 
understand the structural consequences of 
both amino acid substitutions, we 
generated a structure model for a 
PstrSTS2-dimer using SWISS-MODEL 
(41). A structure model for the pinosylvin 
synthase of P. sylvestris (PDB code: 
1U0U, (42)), which was not among the 
pinosylvin synthases tested by us, served 
as template for the calculated model since 
this enzyme shares 87% sequence identity 
to PstrSTS2 on the protein level. A 
structural alignment with structure models 
from the closely related chalcone synthase 
from Medicago sativa with coenzyme A 
bound (PDB code: 1BQ6 (43)) and the 
stilbene synthase from Arachis hypogaea 
with resveratrol bound (PDB code: 1Z1F 
(44)) helped us to pinpoint the active site 
in the calculated PstrSTS2 model. Both 
substitutions are not in close proximity to 
the assumed active sites of the PstrSTS2 
dimer (Fig. 5A). T248 is located in the 
middle of a long β-strand and its side 
chain is facing the interior of the protein at 
the dimer interface. The substitution by an 
L-alanine at this position could simply 
improve the flexibility of the protein and 
might ultimately lead to the observed 
improvement of the STS activity in E. coli. 
In contrast, Q361 is positioned at the end 
of an α-helix on the protein surface and 
located next to the amino acid sequence 
N362-G363-C364. This pattern follows the 
typical N-glycosylation sequence N-X-
S/T/C of L-asparagine (N)-linked protein 
glycosylation, where “X” can be any amino 
acid except L-proline (45, 46). Analysis of 
the PstrSTS2 amino acid sequence with 
the web server “GlycoEP” also identified 
N362 as potential site for N-glycosylation 
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in this particular STS (47). E. coli cannot 
perform L-asparagine (N)-linked protein 
glycosylation. Hence, substitution of L-
glutamine with the more hydrophilic L-
arginine at position 361 might simply lead 
to an improved stability or solubility of 
PstrSTS2 in the absence of any 
glycosylation in the heterologous host. 
When both amino acid substitutions were  
 
FIG 5 (A) Cartoon representation of a close-up of the pinosylvin synthase STS2 from P. 
strobus. The structure model was calculated using the model of the pinosylvin synthase of P. 
sylvestris as template. The monomers are shown in green and purple, resveratrol (Res) and 
coenzyme A (CoA) highlighted in one monomer are shown in the stick mode in yellow and 
cyan/orange, respectively. T248 is located at the dimer interface, whereas Q361 is located 
on the protein surface. Both amino acids are shown in the stick mode. (B) T248 and Q361 
both interact with the C-terminal β-strand shown in orange. The β-strand, in which T248 is 
located, is adjacent to this C-terminal β-strand and the α-helix of Q361 interacts indirectly 
with the same C-terminal β-strand via a loop. 
combined, no pinosylvin synthesis could 
be observed, suggesting that this enzyme 
variant is inactive. The β-strand, in which 
T248 is located, is adjacent to the C-
terminal β-strand of PstrSTS2 and the α-
helix of Q361 interacts indirectly with the 
same C-terminal β-strand via a loop (Fig. 
5B). Possibly, the combination of both 
mutations simply destabilizes the 
architecture of PstrSTS2 rendering this 
enzyme variant inactive. 
 Key to success for the microbial 
production of pinosylvin from glucose 
without supplementation of any 
phenylpropanoid intermediate was the 
combination of various metabolic 
engineering approaches and protein 
engineering of a heterologously expressed 
key enzyme. However, at this point the 
addition of cerulenin is still required for 
achieving significant product titers. This 
could be circumvented by carrying out 
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multiple genetic alterations of the central 
carbon metabolism to redirect the carbon 
flux to malonyl-CoA as it has been done 
for the microbial synthesis of the flavanone 
naringenin with E. coli (48). Here, the 
successful modifications suggested by the 
Optforce model included the 
overexpression of the genes for the 
pyruvate dehydrogenase multi-enzyme 
complex, phosphoglycerate kinase, acetyl-
CoA carboxylase and deletion of the 
genes encoding for the fumarase and 
succinyl-CoA synthetase. Following this 
strategy, 5.6 times higher naringenin titers 
could be attained. 
 Nonetheless, protein engineering 
by directed evolution in the genetic context 
of the synthetic pathway as presented in 
this manuscript could also be used to 
“harmonize” the entire pinosylvin pathway 
with E. coli for achieving higher product 
titers. This strategy might also be useful 
during the development of other microbial 
strains for the production of small 
metabolites of high value.  
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Microbes are extensively engineered to produce compounds of 
biotechnological or pharmaceutical interest. However, functional integration of 
synthetic pathways into the respective host cell metabolism and optimization of 
heterologous gene expression for achieving high product titers is still a challenging 
task. In this manuscript we describe the optimization of a tetracistronic operon for the 
microbial production of the plant-derived phenylpropanoid p-coumaryl alcohol in E. 
coli. This was achieved by advancing the phosphorothioate-based ligase-independent 
gene cloning method for the rapid combinatorial assembly of synthetic operons. 
Operon libraries constructed with this method offer the opportunity for simultaneously 
balancing of gene expression on the level of translation to maximize product titers. 
This method is sequence independent, enzyme free, allows for easy automation due to 
its simplicity and modularity. 
 
Tools and methods of synthetic 
biology have become increasingly 
important to design, assemble and 
optimize biosynthetic pathways for the 
biotechnological production of fine 
chemicals (1), biofuels (2), 
pharmaceuticals (3) or natural products 
(4).  
Tuning of gene expression from 
such synthetic pathways can be achieved 
on the level of transcription or translation. 
Transcription in particular has been in the 
focus of metabolic engineering since many 
years, as a myriad of different (inducible) 
natural promoters are known and have 
been successfully used for the tuning of 
gene expression. Furthermore, 
engineering of the promoter architecture 
has achieved tunable gene expression 
from synthetic promoters in various 
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industrially relevant platform organisms 
such as Escherichia coli (5) or 
Saccharomyces cerevisiae (6). Gene 
expression on the translational level can 
be controlled via adaptation of the codon 
usage (7) during the design of the 
synthetic genes, modulation of the mRNA-
stability (8), application of metabolite-
responsive riboswitches (9) or design of 
the ribosomal binding site (RBS) (10). 
However, considering the complexity of 
gene expression, a balanced expression 
of multigene pathways for achieving 
optimal catalytic efficiencies still 
represents a major challenge, especially if 
genes of the respective pathways originate 
from different organisms. Combinatorial 
assembly and subsequent evaluation of 
many different pathway variants can be a 
very time consuming and expensive task 
depending on the cloning methods 
employed. Many DNA assembly 
techniques have been developed over the 
past few years to complement the more 
traditional cloning, which is based on the 
use of enzymes for in vitro DNA restriction 
and ligation (11). Among the more 
prominent methods for the assembly of 
pathways are Polymerase cycling 
assembly (PCA) (12), Gibson assembly 
(13), the Sequence and ligation 
independent cloning (SLIC) method (14) or 
USER-fusion (15). 
The Phosphorothioate-based 
ligase-independent gene cloning (PLICing) 
method has been developed as an 
enzyme-free and sequence-independent 
cloning method (16) of single genes. 
PLICing starts with amplification of the 
target gene and the vector by PCR using 
primers with complementary 
phosphorothioated nucleotides at the 5´-
end. The PCR products are cleaved in an 
iodine/ethanol solution, yielding single-
stranded overhangs. Subsequently, these 
ends hybridize at room temperature and 
the resulting DNA constructs can be 
directly transformed into competent host 
cells. PLICing is sequence independent, 
and has found numerous applications in 
the field of protein engineering for 
performing simultaneous site-saturation of 
five codons in single genes (17, 18) and 
for recombining secondary structure 
elements, motifs or domains of single 
proteins (19). 
In this study, we advanced the 
PLICing method for the rapid assembly of 
synthetic pathways and included the 
possibility to simultaneously tune 
(“balance”) the expression of all pathway 
genes on the level of translation. This 
balancing is required for maximizing 
product titers and for minimizing inclusion 
bodies formation and potentially cytotoxic 
effects of accumulating pathways 
intermediates.  
Model pathway for the 
development of this method was a four-
step pathway to convert the amino acid L-
tyrosine to the monolignol p-coumaryl 
alcohol (Figure 1). This plant natural 
product is an important precursor of 
pharmaceutically interesting lignans and 
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key building block of the plant polymer 
lignin. p-coumaryl alcohol synthesis from 
L-tyrosine starts with a deamination step 
catalyzed by a tyrosine ammonia lyase 
(TAL, EC 4.3.1.23) to form p-coumaric 
acid. Subsequently, this acid is coenzyme 
A (CoA)-activated by a 4-coumarate-CoA-
ligase (4CL, EC 6.2.1.12). The resulting p-
coumaryl-CoA is reduced to p-coumaryl 
alcohol in two subsequent steps by a 
cinnamoyl-CoA-reductase (CCR, 1.2.1.44) 
and a cinnamyl alcohol dehydrogenase 
(CAD, EC 1.1.1.195). The heterologous 
production of p-coumaryl alcohol was 
recently established in Escherichia coli, 
but without precursor feeding a final 
product titer of only 22 mg/L p-coumaryl 
alcohol could be achieved (20). This was 
explained by the observed cytoplasmatic 
aggregation of insoluble heterologous 
proteins in inclusion bodies. 
 
 
Figure 1. Biosynthetic pathway for the production of p-coumaryl alcohol from L-tyrosine.  
 
At the beginning of our 
experiments, four genes encoding the 
tyrosine ammonia lyase from Rhodobacter 
sphaeroides (RsTAL), the 4-coumarate-
CoA-ligase from Petroselinum crispum 
(Pc4CL), the cinnamoyl-CoA-reductase 
from Zea mays (ZmCCR) and the 
cinnamyl alcohol dehydrogenase from Zea 
mays (ZmCAD) were codon optimized for 
the heterologous expression in E. coli and 
synthesized. Initially, three plasmid-based 
variants of a tetracistronic p-coumaryl 
alcohol pathway were constructed. In all 
cases the transcription was controlled by a 
single IPTG-inducible T7 promoter and the 
translation of each gene in the pathways 
was modulated by an individual, but 
always identical Shine-Dalgarno (SD) 
sequence (5´-TAAGGAGGT-3´) as 
prokaryotic ribosome binding site 
(pALXtreme-1a_T7prom>Rstal-Pc4cl-
Zmccr-Zmcad). The pathways differed only 
in the length (spacing) of the nucleotide 
sequence between SD-sequence and the 
START codon of each gene. The length of 
this short spacing is known to have major 
influence on the translation initiation 
efficiency (21). A spacing of 5 nucleotides 
(nt) between these two regulatory 
elements confers the optimal translational 
efficiency, whereas a deviation from this 
length (either a reduction or an elongation) 
results in stepwise decreased translation 
efficiency. In the first pathway variant (5-5-
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5-5 variant) this spacing was set to 5 nt for 
each gene, in the second pathway (9-9-9-
9 variant) to 9 nt and in the third pathway 
(13-13-13-13 variant) to 13 nt with the aim 
to generate three reference strains with a 
high, medium and low expression of the 
four synthetic p-coumaryl-alcohol pathway 
genes.  
Subsequently, relative 
cytoplasmatic protein concentrations in 
cell free extract (CFE) were determined to 
verify that the variation of the spacing 
between the SD sequence and the START 
codon can indeed modulate the translation 
efficiency for each heterologously 
expressed protein. This was achieved by 
targeted proteomics applying isotope 
dilution mass spectrometry coupled to high 
performance liquid chromatography 
(IDMS-LC-MS/MS) (22). This method 
using 15N-metabolic labeling of the target 
proteins as internal standards allows 
reliable peptide and protein quantification 
in CFEs as complex biological samples 
without the need for a complete separation 
of the respective analytes. For this 
purpose, four proteotypic peptides, 
generated by trypsin-digestion of CFEs, 
had to be identified by LC-MS/MS for each 
enzyme to serve as signature peptides 
during relative protein quantifications. The 
ratio of the areas for these peptides as 
determined by LC-MS/MS for each of the 
four enzymes in comparison to the same 
peptides in the 15N-labeled form (added to 
the samples as internal standards), was 
used for relative protein quantification. The 
results obtained for the SD sequence – 
START-codon spacing of 5 nt was set to 1 
for comparison of the obtained results 
(Figure 2). As expected, the highest 
cytoplasmatic protein concentrations were 
obtained with a spacing of 5 nt for all four 
heterologously expressed genes. With an 
increasing length of this spacing the 
relative cytoplasmic amount of all four 
proteins decreased stepwise. However, to 
a different degree for each protein. For 
instance, RsTAL expression was reduced 
by 75% when increasing the SD 
sequence-START codon spacing from 5 nt 
to 9 nt, but the amount of the Pc4CL was 
only reduced by 10%.  
All three strains were subsequently 
characterized regarding their capability to 
produce p-coumaryl alcohol to find out if 
the observed decreased translation 
efficiency is also reflected by the product 
titers. The obtained results showed 
indeed, that the engineered variation of 
the SD sequence - START-codon spacing 
modulates overall product titers: The 5-5-
5-5 variant accumulated up to 40 mg/L p-
coumaryl alcohol, whereas a product 
concentration of 12 mg/l could be 
determined in the supernatant of the 9-9-
9-9 variant. For the 13-13-13-13 variant 
the lowest p-coumaryl alcohol titer of only 
5 mg/L could be measured.  
Encouraged by these results we 
constructed the first combinatorial p-
coumaryl-alcohol operon library with a  
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Figure 2. Relative cytoplasmatic protein concentrations of RsTAL, Pc4CL, ZmCCR and ZmCAD when 
heterologously expressed in E. coli BL21 (DE3) lacIQ1. For each protein, three gene variants with 
different SD sequence - START codon spacings (5, 9, or 13 nt) were expressed. Relative protein 
concentrations were determined by IDMS-LC-MS/MS, and results for each protein, whose gene had a 
5 nt SD sequence - START codon spacing upstream of the open reading frame was set to 1 for 
comparison. 
variation of the translation efficiency for 
each gene in the four-step pathway 
following the PLICing principle (Figure 3). 
For this purpose, three versions of each 
gene, having either a 5, 9 or 13 nt SD 
sequence - START codon spacing were 
generated by PCR with phosphorothioate-
oligonucleotides (Table S1). The twelve 
resulting PCR products and the 
pALXtreme backbone, which was also 
PCR amplified with phosphorothioate-
oligonucleotides were individually 
subjected to chemical cleavage of the 
phosphorothioate bonds for generating 
complementary 3´-overhangs. Key to the 
combinatorial assembly of the pathway 
variants was the design of the 
complementary sequences required for 
hybridization of the five individual 
fragments, which make up a full operon. In 
this experiment, each of the required five 
sequences was unique to keep the gene 
order (Rstal-Pc4cl-Zmccr-Zmcad) of the 
synthetic p-coumaryl-alcohol operon 
during the process of random assembly 
constant. This limited the number of  
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Figure 3. Combinatorial assembly of synthetic p-coumaryl-alcohol operons employing the PLICing 
principle. Three different variants of each gene, having either a 5, 9 or 13 nt SD-sequence - START 
codon spacing (indicated by different hachures upstream of the respective open reading frames) were 
generated by PCR with phosphorothioate-oligonucleotides. Subsequently, the phosphorothioate 
bonds were cleaved for generating complementary 3´-overhangs. The resulting twelve different gene 
fragments and the vector fragment were mixed in 81 independent hybridization reactions to yield all 
possible combinations of the tetracistronic p-coumaryl-alcohol operon prior to transformation to E. coli. 
  
pathway variants to 81 (34) different 
operon configurations as three different 
SD sequence – START codon spacings 
are possible for each of the four genes. 
Simplicity and robustness of the PLICing 
procedure allowed the individual 
construction of all 81 variants from PCRs 
to the final library in a few days (Table 1). 
After verification of the 
completeness of each operon by colony 
PCR, cultivation and screening in the 96-
well plate format for the production of p-
coumaryl alcohol of this operon library was 
performed. HPLC-analysis of the 
supernatant of all strains revealed that the 
81 variants can be divided in three distinct 
groups according to SD sequence –  
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Table 1. All 81 synthetic p-coumaryl alcohol operon variants differing in the combination of the SD 
sequence-START codon spacing (5 nt, 9 nt, 13 nt) for the genes of the tetracistronic synthetic operon. 
All variants of the operon were cloned into the pALXtreme vector backbone (16) (general scheme: 
pALXtreme-1a_T7prom>x-Rstal-x-Pc4cl-x-Zmccr-x-Zmcad) and subsequently transformed to E. coli 
BL21 (DE3) lacIQ1 (relevant characteristics of the genotype: F- ompT hsdSB(rB-, mB-) gal dcm (DE3)). 
Variant SD seq.-START 
spacing Variant 
SD seq.-START 
spacing Variant 
SD seq.-START 
spacing 
1 5-5-5-5 28 9-5-5-5 55 13-5-5-5 
2 5-5-5-9 29 9-5-5-9 56 13-5-5-9 
3 5-5-5-13 30 9-5-5-13 57 13-5-5-13 
4 5-5-9-5 31 9-5-9-5 58 13-5-9-5 
5 5-5-9-9 32 9-5-9-9 59 13-5-9-9 
6 5-5-9-13 33 9-5-9-13 60 13-5-9-13 
7 5-5-13-5 34 9-5-13-5 61 13-5-13-5 
8 5-5-13-9 35 9-5-13-9 62 13-5-13-9 
9 5-5-13-13 36 9-5-13-13 63 13-5-13-13 
10 5-9-5-5 37 9-9-5-5 64 13-9-5-5 
11 5-9-5-9 38 9-9-5-9 65 13-9-5-9 
12 5-9-5-13 39 9-9-5-13 66 13-9-5-13 
13 5-9-9-5 40 9-9-9-5 67 13-9-9-5 
14 5-9-9-9 41 9-9-9-9 68 13-9-9-9 
15 5-9-9-13 42 9-9-9-13 69 13-9-9-13 
16 5-9-13-5 43 9-9-13-5 70 13-9-13-5 
17 5-9-13-9 44 9-9-13-9 71 13-9-13-9 
18 5-9-13-13 45 9-9-13-13 72 13-9-13-13 
19 5-13-5-5 46 9-13-5-5 73 13-13-5-5 
20 5-13-5-9 47 9-13-5-9 74 13-13-5-9 
21 5-13-5-13 48 9-13-5-13 75 13-13-5-13 
22 5-13-9-5 49 9-13-9-5 76 13-13-9-5 
23 5-13-9-9 50 9-13-9-9 77 13-13-9-9 
24 5-13-9-13 51 9-13-9-13 78 13-13-9-13 
25 5-13-13-5 52 9-13-13-5 79 13-13-13-5 
26 5-13-13-9 53 9-13-13-9 80 13-13-13-9 
27 5-13-13-13 54 9-13-13-13 81 13-13-13-13 
 
START codon spacing for the gene 
encoding the RsTAL (Figure 4). This first 
enzymatic step of the pathway appears to 
be crucial for the overall pathway 
performance. All 27 variants (variants 1 - 
27) with a 5 nt spacing upstream of the 
Rstal START codon are characterized by 
higher product concentrations (up to 55 
mg/L p-coumaryl alcohol) compared to the 
27 variants with a 9 nt spacing upstream 
of the Rstal-gene (variants 28 – 54; 
accumulation of up to 24 mg/L p-coumaryl 
alcohol). Only up to 9 mg/L p-coumaryl 
alcohol could be detected in the  
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Figure 4. p-coumaryl alcohol titers of all 81 constructed variants of the synthetic p-coumaryl alcohol 
operon. The clones are numbered from 1 – 81 in accordance to table 1. The microtiter plate screening 
was performed in triplicate. 
supernatant of clones 55 – 81, all 
harboring operon variants in which the 
Rstal-gene is characterized by a SD 
sequence – START codon spacing of 13 
nt. These results are in accordance with 
determined kinetic parameters of various 
plant derived L-tyrosine ammonia lyases 
as these enzymes generally display a low 
catalytic activity (23-25). This would 
explain the need for maximizing the 
translation efficiency in the genetic 
environment of the synthetic p-coumaryl 
alcohol operon to compensate for low TAL 
activity in E. coli. Under microtiter plate 
screening conditions no general trend for 
the translation efficiency of the other three 
enzymes was visible. However, during 
screening, a few variants within the best 
performing group accumulated more 
product compared to the 5-5-5-5 variant, 
indicating that best translation efficiency 
might not be optimal for highest product 
titers.  
For a deeper insight, shake flask 
experiments for all 27 clones within this 
group were performed. The determined p-
coumaryl alcohol concentrations were put 
in relation to biomass by simply dividing 
the determined product titers by the optical 
density (OD600) of the respective culture at 
the point of measurement. This was done 
although only negligible differences in 
growth could be detected. Unfortunately, 
again no pattern, identifying optimal 
translation conditions for the Pc4CL, 
ZmCCR and ZmCAD could be identified 
(Figure 5). However, variant 5-5-5-5 was 
among the poorest producers,  
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Figure 5. p-coumaryl alcohol titers of E. coli 
clones expressing operon variants 1 – 27. 
Each variant encodes the Rstal gene with a SD 
sequence – START codon spacing of 5 nt. The 
titers have been corrected for differences in 
OD600 at time of sampling after 12 h. The 
shake flask experiments were performed in 
duplicate. 
 
accumulating only up to 10.3 mg/L/OD600 
p-coumaryl alcohol. This supports the 
notion that a maximum of translation 
efficiency for all four enzymes of this 
pathway has a negative effect on product 
formation. In contrast, for the top five 
producers 14.6 – 16.1 mg/L/OD600 p-
coumaryl alcohol could be detected in the 
supernatant after 12 h (variants: no. 12 (5-
9-5-13); no. 14 (5-9-9-9); no. 15 (5-9-9-
13); no 18 (5-9-13-13); no. 23 (5-13-9-9). 
A decreased translation efficiency of the 
other enzymes possibly decreased the 
metabolic burden for the microbial host 
with respect to protein synthesis, thus 
balancing the pathway and probably 
increasing the availability of the precursor 
amino acid L-tyrosine for phenylpropanoid 
synthesis. Extracellular concentrations of 
p-coumaric acid as product of the RsTAL-
catalyzed deamination of L-tyrosine and 
first pathway intermediate were always 
similar (≤ 3 mg/L), indicating that RsTAL-
activity is still limiting the overall product 
titer despite high expression in E. coli. The 
absolute product titer for these five 
variants ranged from 47.6 to 52 mg/L p-
coumaryl alcohol without any further 
optimization of growth and production 
conditions. Thus, balancing of the 
synthetic pathway already more than 
doubled the overall product titer compared 
to the previously engineered E. coli strain 
expressing the same genes which 
accumulated only up to 22 mg/L p-
coumaryl alcohol without precursor 
feeding (20).  
The modularity and simplicity of the 
PLICing method also offers the opportunity 
to generate the whole operon library of 81 
variants in a single reaction tube by simply 
combining the 12 amplified and cleaved 
gene fragments and the equally treated 
plasmid fragment prior to hybridization and 
transformation of E. coli. Such a library 
was generated and 300 clones were 
screened for p-coumaryl alcohol 
production in 96 deep-well plates using 
three-times oversampling to statistically 
ensure screening of 95% of all possible 
variants (26). The three individually 
constructed reference variants (5-5-5-5, 9-
9-9-9 and 13-13-13-13) and a strain 
harboring the empty vector served as 
controls. Screening and rescreening of the 
best hits successfully identified the 5-9-9-9 
variant, which was also among the best 
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variants in the manually generated library. 
However, some good variants were 
missing raising the question whether the 
library was complete. DNA sequencing of 
randomly selected clones of the library 
surprisingly revealed that not all E. coli 
clones harbored plasmids with a complete 
synthetic p-coumaryl alcohol operon. This 
was surprising as the five sequences used 
as points of hybridization during PLICing 
were all unique and assembly of all five 
fragements is necessary for circularization. 
Especially the Zmcad-gene was frequently 
missing. Incomplete pathway assembly 
was also found during previous studies 
using the CLIVA method which takes also 
advantage of the PLICing principle (27). 
Here the number of fully assembled 
operon variants dropped dramatically 
when more genes were supposed to be 
assembled.  
 Nonetheless, this method for the 
combinatorial assembly of synthetic 
pathways described in this manuscript 
allows the rapid construction of a large 
number of operon variants. The method is 
sequence-independent and thus does not 
require any specific recognition or target 
sequences for enzymatic activities since 
all hybridization sites can be arbitrarily 
selected. In fact, after PCR-amplification, 
no enzymes such as endonucleases or 
ligases, which are frequently used in other 
methods, are needed. The modularity, 
simplicity and robustness of this method 
would be perfectly suited for an 
automation of cloning in the microtiter 
plate format. During the combinatorial 
optimization of the p-coumaryl alcohol 
operon, only the SD sequence – START 
codon spacing was modulated. However, 
any other regulatory elements of gene 
expression could also be varied during 
pathway balancing. Furthermore, five 
unique hybridization sequences, limiting 
the overall complexity of the generated 
library to only 81 variants, were used in 
this study. Decreasing the number of 
these sequences (and keeping the number 
of hybridization sites constant), possibly 
even using only a single sequence, would 
allow randomization of the gene order and 
randomization of the number of genes in 
the operon library. The latter effect would 
offer the opportunity to vary the “dosis” of 
individual genes in the pathway. This 
would also represent a possible solution to 
overcome the low TAL activity within the p-
coumaryl alcohol pathway, which currently 
limits the product titers in E. coli. However, 
one has to bear in mind that the 
transformation efficiency drastically 
decreases with an increasing plasmid size 
(20). Currently, downside of this method is 
the observed low cloning efficiency when 
the five DNA-fragments were assembled in 
a single reaction tube. Again, the 
modularity of PLICing could be a solution. 
When a performed prescreening of an 
operon library identifies a certain 
configuration as most beneficial, this 
parameter can be fixed by simply using 
other PCR-primer combinations and 
amplification of different DNA-fragments 
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prior to construction of another library. In 
case of the p-coumaryl alcohol operon, the 
5 nt-Rstal fragment, which was identified 
as being essential for high product titers, 
can be fused to the vector fragment, 
thereby reducing the overall number of 
fragments to be randomly assembled 
during the construction of the next library 
of synthetic operons. 
 
Methods 
Strains and plasmids. E. coli 
BL21-Gold (DE3) lacIQ1 and the plasmid 
pALXtreme-1a were used for cloning and 
expression purposes (16). The cells were 
routinely cultivated on a rotary shaker (170 
rpm) at 37°C in Luria–Bertani (LB) medium 
or on LB plates (LB medium with 1.5% 
[wt/vol] agar) (28). If appropriate, 
kanamycin (50 µg/mL) was added. Growth 
was determined by measuring the optical 
density at 600 nm (OD600). 
Genes and primers. Genes 
encoding the tyrosine ammonia lyase from 
Rhodobacter sphaeroides (RsTAL), the 4-
coumarate: CoA ligase from Petroselinum 
crispum (Pc4CL), the cinnamoyl-CoA 
reductase from Zea mays (ZmCCR) and 
the cinnamyl–alcohol dehydrogenase, also 
from Zea mays (ZmCAD) were chemically 
synthesized by GeneArt Gene Synthesis 
services from Life Technologies, a Thermo 
Fisher Scientific company (Waltham, MA, 
USA). Genes were codon optimized for 
expression in E. coli employing the 
proprietary GeneOptimizer software. 
Oligonucleotide primers were purchased 
from Eurofins Genomics (Ebersberg, 
Germany). Primers used in this study are 
summarized in table S1 (Supplemental 
material). 
PCR amplification of target 
genes and vector for PLICing. All genes 
and the pALXtreme-1a vector backbone 
were amplified by PCR from plasmid 
template DNA. PCRs were performed in a 
final volume of 50 µL in a T3000 
thermocycler from Biometra (Göttingen, 
Germany) using thin walled PCR tubes 
(Bio-Budget, Krefeld, Germany). Typically, 
PCR reactions were composed of 1x KOD 
Hot Start DNA polymerase buffer (Merck 
Millipore, Billerica, MA, USA), 1.5 mM 
MgSO4, 0.2 mM dNTP mix, 0.3 µM 
phosphorothioate forward and reverse 
oligonucleotides (PTOs) (Table S1), 20 ng 
template DNA, and 1U KOD Hot Start 
DNA polymerase. PCR-cycling started with 
an initial denaturation step at 96°C for 2 
min. Subsequently, three cycles (96°C, 20 
s; 50°C, 30 s; and 72°C, 120 s), followed 
by 28 cycles (96°C, 20 s; 55°C, 30 s; and 
72°C, 120 s) and one fill-up cycle (72°C, 5 
min) were performed. All PCR reactions 
were subjected to DpnI digestion (10U, 16 
h, 37°C) prior to purification of the PCR 
products using a PCR purification kit 
(Macherey–Nagel, Düren, Germany) 
according to manufacturer’s instructions. 
Subsequently, PCR products were 
quantified using a NanoDrop ND-1000 
spectrophotometer (NanoDrop 
Technologies, Wilmington, DE, USA). For 
increased PLICing efficiency, a second 
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PCR reaction with the same composition 
was performed using the amplified DNA 
fragments from the first PCR reaction as 
template. For this purpose, 30 PCR cycles 
(96°C, 20 s; 55°C, 20 s; and 72°C, 60 s) 
and one fill-up cycle (72°C, 5 min) after the 
initial denaturation step (96°C, 2 min) were 
performed. Again, the PCR products were 
purified using a PCR purification kit 
(Macherey–Nagel, Düren, Germany). 
Agarose–TAE gel electrophoresis was 
performed according to standard protocols 
to confirm the presence and correct size of 
the amplified genes and the pALXtreme-
1a vector backbone (28). 
Construction of the p-coumaryl 
alcohol operon variants using PLICing. 
The iodine cleavage reactions for PLICing 
were prepared by mixing 4 µL of the PCR 
amplified genes (concentrations varied 
from 0.26 - 0.36 pmol/µL) or 1 µL of the 
PCR amplified vector backbone DNA, 
which was adjusted to 4 µL with Milli-Q 
water (0.06 pmol/µL), with 1 µL cleavage 
buffer (0.5 M Tris–HCl, pH 9.0), 0.6 µL 
iodine stock solution (100 mM iodine in 
99% ethanol), and 0.4 µL Milli-Q water to a 
final volume of 6 µl in thin-walled PCR 
tubes. DNA cleavage was performed by 
incubating the reaction mixtures at 70°C 
for 10 minutes (Biometra T3000 
thermocycler). The resulting DNA 
fragments were used directly for 
hybridization of the DNA fragments without 
any further purification. DNA hybridization 
was achieved by sequentially combining 
the pALXtreme-1a vector backbone, Rstal, 
Pc4cl, Zmccr and Zmcad iodine cleavage 
mixtures with 5 minutes incubation 
intervals at room temperature after the 
addition of each DNA fragment. After a 
final incubation step at room temperature 
for 5 minutes, 4 µL of this hybridization mix 
was used to transform 100 µl chemically 
competent E. coli BL21-Gold (DE3) lacIQ1 
cells by the RbCl method (29).  
In order to verify that all four genes 
of the synthetic p-coumaryl alcohol 
pathway were successfully incorporated 
into the vector backbone, recombinant 
clones were analyzed by colony PCR. A 
master mix with 1x Dream Taq green 
master mix (Thermo Scientific, Waltham, 
MA, USA) and 0.3 µM forward and reverse 
primer (Table S1) was prepared and 20 µl 
aliquots of this master mix were dispensed 
into thin walled PCR tubes. Colonies were 
directly transferred from LB agar plates 
into the PCR tubes with sterile toothpicks. 
Cycling started with an initial denaturation 
at 95°C for 3 min, followed by 30 cycles 
(95°C, 30 s; 60°C, 30 s; and 72°C, 4 min) 
and one fill-up cycle (72°C, 5 min). The 
PCR reactions were analyzed on 
agarose–TAE gels. The p-coumaryl 
alcohol operon of randomly selected 
clones was sequenced to confirm the 
correct assembly of the synthetic operons. 
Microtiter plate screening and 
shake flask cultivations for the 
microbial production of p-coumaryl 
alcohol. Clones of the generated PLICing-
libraries were picked from the LB plates 
into 96 well microtiter plates (BRAND,
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Wertheim, Germany) with 100 µL LB 
medium per well. These precultures were 
incubated overnight for 16 hours at 37°C 
in a microtron shaker from Infors (900 rpm 
and 75% humidity, [Bottmingen, 
Switzerland]). 96-well deepwell plates 
(Eppendorf, Hamburg, Germany) with 600 
µL LB medium and 1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) per well 
were inoculated with 6 µl from each 
preculture. The deepwell plates were 
incubated at 25°C for 24 hours in the 
microtron shaker (900 rpm, 75% humidity). 
The cell-free culture medium was 
harvested by centrifugation (4°C, 3,500 g, 
30 min,) for the determination of product 
and intermediates. For p-coumaryl alcohol 
production at shake flask scale, 50 mL LB-
medium in 500 mL baffled shake flasks 
was inoculated with 500 µL of an over-
night culture and incubated at 37°C and 
120 rpm shaking until the OD600 reached 
0.2. Subsequently, the cultivation 
temperature was decreased to 25°C and 
heterologous gene expression was 
induced with 1 mM IPTG when the OD600 
reached 0.6. The cultivation continued at 
25°C for an additional 24 hours. Samples 
were taken at regular time intervals for 
product analysis.  
Determination p-coumaric acid 
and p-coumaryl alcohol by uHPLC. p-
coumaryl alcohol and p-coumaric acid 
concentrations in the cell-free culture 
supernatant were determined by ultra-
high-performance LC (uHPLC). For this 
purpose, 2 µL of the supernatant was 
injected into an Agilent 1290 infinity LC 
(Santa Clara, CA, USA) using 0.1% 
(vol/vol) acetic acid in water (buffer A) and 
0.1% (vol/vol) acetic acid in acetonitrile 
(buffer B) as the mobile phases at a flow 
rate of 0.4 mL min-1. The LC separation 
was carried out using a ZORBAX Eclipse 
AAA (3.5 µm, 4.6 x 75 mm) column with a 
guard cartridge (4.6 x 12.5 mm) from 
Agilent at 40°C. For an efficient 
separation, a gradient was used, where 
buffer B was increased from 15% to 60% 
over 10 minutes. Under these conditions, 
the retention time of p-coumaryl alcohol 
was 4.9 min, wheras p-coumaric acid 
eluted after 5.3 min. The compounds were 
detected by monitoring the absorption at 
275 nm. The p-coumaric acid standard 
was purchased from Sigma-Aldrich (St. 
Louis, MO, USA), while p-coumaryl alcohol 
was purchased from MicroCombiChem 
(Wiesbaden, Germany).  
Relative protein quantification. 
Relative protein quantification was 
performed as previously described (22). 
For the generation of 15N-labelled protein 
of each target enzyme to serve as internal 
standards during analyses, cells were 
cultivated in M9 defined medium 
supplemented with 50 µM FeSO4 and 1 
µM ZnSO4. Glucose (4%) was added as 
carbon source and 15NH4Cl served as sole 
nitrogen source. For the generation of 
protein samples, shake flask cultures were 
harvested 6 hours after induction with 
IPTG by centrifugation (4°C, 6,000 g for 10 
min). The cell pellets were washed with a 
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0.9 wt% NaCl solution and centrifuged 
again (4°C, 6,000 g for 10 minutes). The 
obtained cells were concentrated 50x in 1 
mL lysis buffer [50 mM potassium 
phosphate buffer, pH 8.0, 2 mM 
ethylenediaminetetraacetic acid (EDTA), 2 
mM dithiothreitol (DTT), supplemented 
with complete protease inhibitor cocktail (1 
697 498, Roche Applied Science)] and 
shortly incubated on ice. Subsequently, 
cells were disrupted by sonication for four 
minutes at 4°C using a Branson sonifier 
250 (intensity 2; duty cycle 20%; Branson, 
[Danbury, CT, USA]). Cell free extracts 
(CFE) were harvested by centrifugation 
(4°C, 16,000 g for 30 min). 
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4. Discussion 
Phenylpropanoids and phenylpropanoid-derived polyphenols are plant natural products with 
potential therapeutic applications for the treatment of various cancers, inflammatory 
diseases, cardiovascular diseases, diabetes and Alzheimer´s disease (18, 74-79). However, 
once a potent PNP is discovered, the ability to produce enough material for clinical 
applications becomes the main limiting factor since the plant usually accumulates the 
desired compound only up to low concentrations. In this context, metabolically engineered 
microorganisms as production platforms for PNPs represent a very promising alternative to 
expensive chemical synthesis and cumbersome PNP-extraction from plants (16).  
The main goal of this thesis was the development of a microbial production strain for the 
production of the stilbene pinosylvin from its precursor L-phenylalanine. Pinosylvin has 
potential application in the treatment of certain cancers, cardiovascular inflammatory 
diseases and adjuvant arthritis (64-67). Introduction of heterologous pathways into microbial 
production strains can pose a big challenge due to an unbalanced expression of the 
individual genes leading to the formation of inclusion bodies or the accumulation of 
potentially toxic intermediates (68). Hence, an additional goal of this thesis was the 
advancement of the Phosphorothioate ligase independent gene cloning method (PLICing) 
(61) to assemble synthetic pathways and balance the heterologous gene expression in 
bacteria. To achieve this, the PLICing technique was used to construct a library of synthetic 
operons. In this library the distance between the Shine Dalgarno (SD) sequence and the 
translation initiation codon of the genes associated with the biosynthetic production of the 
monolignol p-coumaryl alcohol from L-tyrosine, was varied.  
Since E. coli already proved to be a suitable host for the production of phenylpropanoid 
derived compounds such as flavonoids (80), stilbenes (81) and coumarins (19), this organism 
was chosen as platform organism during this work. Construction of an efficient microbial 
production strain for  PNPs requires the identification and selection of suitable enzymes, the 
assembly of stable genetic constructs for balanced gene expression and the adaptation of 
the host cell metabolism (pre-cursor/co-factor supply, removal of competing or degradation 
pathways) to the synthetic pathway (or vice versa). 
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4.1 Microbial pinosylvin production with Escherichia coli 
Development of stilbene producing microorganisms has been mostly limited to strains 
requiring the supplementation of phenylpropanoid precursors (e.g. p-coumaric acid, trans-
cinnamic acid, ferulic acid, caffeic acid or sinapic acid). This strategy has led to some 
considerable success with regard to the stilbene resveratrol, where feeding of p-coumaric 
acid resulted in maximum product titers of 2.3 g/L in E. coli when supplementing the fatty 
acid biosynthesis pathway inhibitor cerulenin (10). While a maximum of only 35 mg/L 
resveratrol was achieved when supplementing L-tyrosine and malonate, the latter 
compound being converted to malonyl-CoA through expression of a malonate synthetase 
(MatB) and malonate carrier protein (MatC) from Rhizobium trifolii (82). In comparison, 
reported product titers for pinosylvin are modest with 0.6 mg/L achieved with Streptomyces 
venezuelae (when supplementing 1.2 mM trans-cinnamic acid) (83) and 155 mg/L achieved 
during biotransformation with E. coli (when providing 1 mM trans-cinnamic acid and 
augmenting intracellular malonyl-CoA levels) (84). 
In this work several engineering strategies were systematically explored for the construction 
of a pinosylvin producing E. coli strain. Suitable enzymes from various microbial or plant 
sources for the three-step conversion starting from the amino acid L-phenylalanine were 
identified through literature and database searches e.g. by employing the BRaunschweig 
ENzyme Database (85) (Figure 4.1). 
 
Figure 4.1 Biosynthetic pathway from L-phenylalanine to pinosylvin. Abbreviations: PAL, 
phenylalanine ammonia lyase; 4CL, 4-coumarate-CoA ligase; STS, stilbene synthase. 
Two enzyme variants were selected for each of the three enzymatic steps on the basis of 
their kinetic properties. The phenylalanine ammonia lyase (PAL), 4-Coumarate-CoA ligase 
(4CL) and stilbene synthase (STS), which catalyze the three subsequent steps from L-
phenylalanine to pinosylvin, were initially expressed under the individual control of a T7-
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promoter. Soluble expression of the plant STSs in E. coli proved to be a difficult task, even 
though all respective genes were codon optimized for expression in E. coli prior to gene 
synthesis. Heterologous gene expression can be tedious especially when the native 
expression organism is more distantly related to the heterologous expression host (86, 87). 
Incomplete folding as a result of absent post-translational modifications and/or the changed 
microenvironment in the heterologous host or the lack of specific molecular chaperones 
could hinder heterologous protein expression as it was described for E. coli (88). Soluble 
expression of the STS from Pinus densiflora (PdSTS3) was unsuccessful even after attempting 
multiple expression strategies. During expression of the pinosylvin biosynthetic pathway in 
E. coli, PdSTS3 could be identified in the insoluble protein fraction by SDS-PAGE analysis and 
the identity of the STS was further confirmed by MALDI-ToF-MS. The N-terminal His6-tag 
fusion protein of the Pinus strobus STS (PstrSTS2) could be expressed in soluble form and 
was identified by SDS-PAGE analysis after purification of the fusion protein on a nickel-
nitrilotriacetic acid column. Even though the His-tag was initially developed as an affinity tag, 
it has also been shown to increase the solubility of some small human proteins expressed in 
E. coli (89). 
After expression optimization studies, both selected PALs (PAL isozyme 1 from Petroselinum 
crispum [PcPAL1] and the PAL isozyme 2 from Arabidopsis thaliana [AtPAL2]) and 4CLs (4CL-
like enzyme from Streptomyces coelicolor [Sc4CL] and a variant of the 4CL isozyme 2 of 
Arabidopsis thaliana [At4CL2]) were combined with the His6-tagged fusion of PstrSTS2 
(HisPstrSTS2). Each of their respective genes was placed under control of their own T7 
promoter to determine the most optimal PAL-4CL-STS combination for pinosylvin 
production. The combination of PcPAL1 and Sc4CL was the most beneficial for pinosylvin 
biosynthesis (up to 0.64 mg/L) followed by the AtPAL2 and Sc4CL combination (up to 0.36 
mg/L). The positive effect of the N-terminal His6-tag on PstrSTS2 expression was also 
reflected by increased pinosylvin titers as the same strain expressing PstrSTS2 without the 
His6-tag, accumulated only up to 0.22 mg/L pinosylvin instead of up to 0.64 mg/L. 
Interestingly, At4CL2 performed better with A. thaliana PAL2 (AtPAL2) than with the PAL 
from P. crispum (PcPAL1). The better performance of the AtPAL2/At4CL2 combination could 
be attributed to the common origin of these enzymes. Moreover these results favor the 
concept of evaluating the performance of an entire synthetic pathway instead of just 
assembling a pathway from individually characterized “best parts”. Further improvement of 
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pinosylvin production could be achieved by organizing the three genes (Pcpal1, Sc4cl and 
HisPstrsts2) in an operon under control of a single T7 promoter (up to 3.37 mg/L). A previous 
study also showed improved resveratrol production, when 4CL and STS genes were 
expressed from an operon-based construct, this possibly led to a more balanced expression 
according to the authors (81). Replacing the IPTG inducible T7 promoter by the constitutive 
promoter Pgap of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from E. coli, 
however did not result in detectable pinosylvin titers. Low levels of trans-cinnamic acid were 
measured (up to 10 mg/L) for the E. coli strain BL21(DE3) pUC18-Pgap-HisPstrsts2-Sc4cl-
Pcpal1. This indicates that all the pathway genes should in principle be expressed as the 
enzyme product of the last gene in the operon (Pcpal1) was detected. Probably expression 
of the genes is insufficient for detectable pinosylvin production when using the Pgap.  
During evaluation of the precursor supply, malonyl-CoA availability was identified as the 
most critical for improving pinosylvin product titers. Addition of the fatty acid biosynthesis 
pathway inhibitor cerulenin increased the pinosylvin titers 18 to 20-fold (in the absence and 
presence of L-phenylalanine, respectively). In contrast, L-phenylalanine alone had no positive 
effect on the product titers. Supply of this amino acid only became limiting during cerulenin-
induced increased malonyl-CoA availability. With the aim to provide more of both 
precursors, it was decided to enhance the intracellular malonyl-CoA levels in the L-
phenylalanine E. coli production strain 4pF20 (71), which would then serve as host for the 
production of phenylpropanoid-derived PNPs. Previous metabolic engineering efforts for 
increasing the intracellular levels of malonyl-CoA in E. coli, which included the 
overexpression of the acetyl-CoA carboxylase (ACC) from C. glutamicum and the native 
acetyl-CoA synthase (ACS), in combination with the deletion of the acetate assimilation 
pathway (ackA-pta) and the ethanol synthesis pathway from acetate (adhE) resulted in a 
15.7 fold increase of intracellular malonyl-CoA levels (Figure 4.2) (72). 
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Figure 4.2 Scheme of central metabolism of E. coli centered on the biosynthesis of malonyl-CoA. 
Genes, which were upregulated for the increased synthesis of malonyl-CoA are depicted in green, 
while genes, which were deleted are depicted in red (72). Abbreviations: Acetyl-P, acetyl-phosphate; 
malonyl-ACP, malonyl-acyl carrier protein; OAA, oxaloacetate; PEP, phosphoenolpyruvate; TCA, 
tricarboxylic acid.  
Unfortunately, the same engineering efforts in E. coli 4pF20(DE3), conducted in this thesis 
did not lead to increased malonyl-CoA or acetyl-CoA levels and simultaneous episomal 
expression of the pinosylvin pathway and the ACC from C. glutamicum, completely abolished 
the pinosylvin production.  
Another strategy to circumvent the addition of cerulenin for increased malonyl-CoA 
availability was the overexpression of the intrinsic β-ketoacyl-acyl carrier protein (ACP) 
synthase II (FabF). In a study by Subrahmanyam and Cronan (90), which investigated the 
inhibitory effect of FabF on phospholipid synthesis, they found that overexpression of FabF 
increased the ratio of malonyl-CoA to the total cellular CoA pool from 0.5% to 40%. Zha et al. 
(72) investigated various metabolic engineering strategies for improving cellular malonyl-
CoA levels in E. coli and reported a fourfold increase of malonyl-CoA compared to wild type 
E. coli K-12 upon overexpression of FabF. FabF is believed to sequester most of the malonyl-
CoA-ACP transacylase (FabD), blocking the interaction of FabD with the β-ketoacyl-acyl 
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carrier protein (ACP) synthases I and III (FabB and FabH, respectively). Consequently, FabB 
and FabH are unable to catalyze essential chain elongation reactions with malonyl-ACP as 
substrate (Figure 4.3), which subsequently leads to an increase of cellular malonyl-CoA (90). 
Unfortunately, this strategy also did not lead to increased pinosylvin titers. In a previous 
study no improvement of the microbial flavonoid production with E. coli was observed upon 
expression of the ACC from C. glutamicum, suggesting that at least this strategy is not 
generally applicable (91).  
To investigate whether the availability of the intermediate trans-cinnamoyl-CoA could also 
be limiting due to low 4CL-activity, a comparative analysis of the trans-cinnamic acid, trans-
cinnamoyl CoA and pinosylvin intracellular levels was done. The addition of 200 µM of 
cerulenin led to an 18-fold increase of pinosylvin, accompanied by a drop of trans-cinnamic 
acid and trans-cinnamoyl-CoA level of only 20% and 30% respectively. Thus the PAL-and 4CL- 
activity in E.coli appear to be sufficient to support higher pinosylvin titers, as their 
intracellular levels are not depleted during pinosylvin biosynthesis. In contrast, expression of 
the STS was still low even though all STS gene sequences were codon optimized for an 
expression in E. coli prior to gene synthesis. Therefore, the poor soluble expression of 
HisPstrSTS2 in E. coli might be limiting the performance of the pinosylvin pathway. 
 
Figure 4.3 The biosynthesis of fatty acids in E. coli, with malonyl-CoA and acetyl-CoA as main 
precursors. 
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Directed protein evolution was performed to adapt the expression of the pine-derived 
HisPstrSTS2 to the microbial host system. The codon optimized open reading frame of 
HisPstrsts2 was randomly mutated by error prone PCR (epPCR) and the resulting STS-library 
was subcloned into a plasmid harboring the Pcpal1 and Sc4cl genes.  After only one round of 
mutagenesis by epPCR and MTP-based screening of 450 clones for increased pinosylvin-
related fluorescence, two clones with improved product formation were identified. In each 
clone a single amino acid substitution was identified in their HisPstrSTS2 variants after 
sequencing of the respective genes. The clone harboring the HisPstrsts2-Q361R variant 
produced 66 mg/L pinosylvin in the presence of 200 µM cerulenin and titers increased to 70 
mg/L when L-phenylalanine was also supplemented. The HisPstrsts2-T248A variant had the 
highest pinosylvin titers compared to the best strain E. coli BL21(DE3) pR-HisPstrsts2-Sc4cl-
Pcpal1. Pinosylvin titers increased from 59 mg/L measured with E. coli BL21(DE3) pR-
HisPstrsts2-Sc4cl-Pcpal1 to 70 mg/L with the HisPstrsts2-T248A variant in the presence of 
200 µM cerulenin, and by an additional 30% to 91 mg/L when L-phenylalanine was also 
supplemented. However, the combination of both mutations had a detrimental effect on 
product formation. 
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Figure 4.4 (A) Cartoon representation of the PstrSTS2 dimer calculated using the structure of the 
pinosylvin synthase of P. sylvestris as model. The monomers are depicted in green and purple, 
resveratrol (Res) and coenzyme A (CoA) highlighted in one monomer are shown in the stick mode in 
yellow and cyan/orange, respectively. (B) T248 is located at the dimer interface, while Q361 is on the 
protein surface. Both amino acids are shown in the stick mode. (C) T248 and Q361 both interact with 
the C-terminal β-strand shown in orange. The β-strand, in which T248 is located, is adjacent to this C-
terminal β-strand, while the α-helix of Q361 interacts indirectly with the same C-terminal β-strand 
via a loop shown in blue. 
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To understand the consequences of the two amino acid substitutions on the structure and 
activity of the STS, a structure model for a PstrSTS2-dimer was generated using SWISS-
MODEL (92) (Figure 4.4A).  The crystal structure from the pinosylvin synthase of P. sylvestris 
(PDB code: 1U0U, (93)), which shares an 87% sequence identity to PstrSTS2 on the protein 
level was used as template for the generation of the PstrSTS2 model. To identify the location 
of the active site in the PstrSTS2 structural model, a structural alignment with the structures 
from the closely related chalcone synthase from Medicago sativa with coenzyme A bound 
(PDB code: 1BQ6 (94)) and the stilbene synthase from Arachis hypogaea with bound 
resveratrol (PDB code: 1Z1F (95)) was performed. Both amino acids, T248 and Q361 are not 
in close proximity to the assumed active site of PstrSTS2 (Figure 4.4B). T248 is located in a β-
strand and its side chain is pointing towards the interior of the protein at the dimer 
interface. Substitution of L-threonine by L-alanine at this position could simply improve the 
flexibility of the protein and might ultimately lead to the observed improvement of the STS 
activity in E. coli. In contrast, Q361 is positioned at the end of an α-helix on the protein 
surface and located next to the amino acid sequence N362-G363-C364, which follows the 
typical N-glycosylation sequence N-X-S/T/C of L-asparagine (N)-linked protein glycosylation ( 
“X” can be any amino acid except L-proline (96, 97)). However, E. coli is not capable of 
performing L-asparagine (N)-linked protein glycosylation. Thus, the substitution of L-
glutamine by the more hydrophilic amino acid L-arginine might simply lead to an improved 
stability or solubility of PstrSTS2 in the absence of any glycosylation in the microbial host. As 
mentioned previously, combining both amino acid substitutions was detrimental to the 
pinosylvin production, suggesting that this enzyme variant is inactive. The β-strand, in which 
T248 is located, is adjacent to the C-terminal β-strand of PstrSTS2, while the α-helix of Q361 
interacts indirectly with the same C-terminal β-strand via a loop (Figure 4.4C). Possibly, the 
combination of both mutations simply destabilizes the structure of PstrSTS2 resulting in an 
inactive enzyme variant. 
4.2 Suggestions to further improve the microbial synthesis of pinosylvin with E. coli 
In order to achieve significant pinosylvin titers during microbial synthesis with E. coli, the 
addition of cerulenin is still required. With the aim to prevent the addition of this inhibitor 
multiple genetic alterations of the central carbon metabolism can be carried out to redirect 
the carbon flux from the glycolysis and citric acid cycle towards malonyl-CoA synthesis. For 
example naringenin production could be increased by a factor of 5.6, after overexpression of 
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genes for the pyruvate dehydrogenase multi-enzyme complex (aceEF and lpdA), the 
phosphoglycerate kinase (pgk), the acetyl-CoA carboxylase (accABCD) and deletion of the 
genes encoding for the fumarase (fumC) and succinyl-CoA synthetase (sucC). These 
modifications were predicted by the OptForce model (a computational procedure, which 
predicts metabolic interventions that lead to the overproduction of a desired biochemical in 
microbial strains (45))  and led to a 4-fold increase of intracellular malonyl-CoA compared to 
the wild type strain (98). Combining the genetic alterations in a L-phenylalanine producer 
strain would directly improve the precursor supply for the STS and PAL enzymes, 
respectively.  
4.3 Combinatorial optimization of synthetic operons for the microbial production of 
p-coumaryl alcohol 
In this study, the PLICing method was further developed for the rapid assembly of synthetic 
pathways. In addition, this method allows for balancing the expression of all pathway genes 
on the level of translation to maximize product titers by avoiding the accumulation of 
potentially toxic intermediates and the formation of inclusion bodies. The model pathway 
for the development of this method was a four-step pathway to convert the amino acid L-
tyrosine to the monolignol p-coumaryl alcohol (Figure 4.5). The heterologous production of 
p-coumaryl alcohol was recently established in Escherichia coli, but without feeding of the 
precursor trans-coumaric acid a final product titer of only 22 mg/L could be achieved (99). 
Formation of inclusion bodies by the heterologously expressed genes was indicated as the 
reason for the low product titers.  
 
Figure 4.5. Biosynthetic pathway for the production of p-coumaryl alcohol from L-tyrosine. 
Abbreviations: TAL, tyrosine ammonia lyase; 4CL, 4-coumarate-CoA ligase; CCR, cinnamoyl-CoA-
reductase; CAD, cinnamyl alcohol dehydrogenase. 
 
In the initial experiments, three plasmid-based variants including the four codon optimized 
genes of the tyrosine ammonia lyase from Rhodobacter sphaeroides (Rstal), the 4-
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coumarate-CoA-ligase from Petroselinum crispum (Pc4cl), the cinnamoyl-CoA-reductase from 
Zea mays (Zmccr) and the cinnamyl alcohol dehydrogenase from Zea mays (Zmcad) were 
constructed. In all variants the transcription was controlled by a single IPTG-inducible T7 
promoter and the translation of each gene was modulated by an individual, but identical 
Shine-Dalgarno (SD) sequence (5´-TAAGGAGGT-3´). The three plasmid variants differed only 
in the spacing between the SD-sequence and the start codon of each gene. The length of this 
short spacing is known to have significant influence on the translation initiation efficiency 
(100). While a spacing of 5 nucleotides (nt) confers the optimal translational efficiency, 
deviation from this optimal length (either shorter or longer than 5 nt) results in stepwise 
decreased translation efficiency. For the three pathway variants the spacing was set to 
either 5 nt (5-5-5-5 variant), 9 nt (9-9-9-9 variant) or 13 nt (13-13-13-13 variant) for each 
gene. The variants were constructed as reference strains with a high, medium and low 
expression of the four synthetic p-coumaryl-alcohol pathway genes, respectively. The 
relative cytoplasmatic protein concentrations in cell free extract (CFE) determined by 
targeted proteomics applying isotope dilution mass spectrometry coupled to high 
performance liquid chromatography (IDMS-LC-MS/MS) verified that the variation of the 
spacing between the SD sequence and the start codon could indeed control the translation 
efficiency for each heterologously expressed gene (101). As expected, the highest 
cytoplasmic protein concentrations were obtained for the 5-5-5-5 variant. With an increasing 
spacer length between the SD-sequence and start codon the relative cytoplasmic amount of 
all four proteins decreased stepwise, however, to a different degree for each protein. The 
level of protein translation was also reflected in the p-coumaryl alcohol production of the 
three reference strains. The 5-5-5-5 variant accumulated up to 40 mg/L p-coumaryl alcohol, 
whereas the 9-9-9-9 variant only accumulated up to 12 mg/l in the supernatant. For the 13-
13-13-13 variant the lowest p-coumaryl alcohol titer of only 5 mg/L was measured.  
After confirming the influence of the SD sequence - START codon spacing on both gene 
expression and concomitant product formation, a p-coumaryl alcohol operon library with 
variation of the translation efficiency of each gene in the four step pathway was constructed 
using the PLICing method.  For this purpose, three versions of each gene, having either a 5, 9 
or 13 nt SD sequence - START codon spacing were manually combined to yield 81 different 
pathway variants in which the order of the genes was kept constant (Rstal-Pc4cl-Zmcad-
Zmccr). HPLC-analysis of the supernatant of all 81 strains revealed that the first enzymatic 
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step of the pathway was the most crucial for the overall pathway performance. Amongst the 
27 strains with the highest translation efficiency for RsTAL (5 nt spacing), a titer of 33 to 55 
mg/L p-coumaryl alcohol could be measured, while the 27 variants with the 9 nt spacing for 
the Rstal gene accumulated up to 24 mg/L p-coumaryl alcohol. For the 27 operon variants, 
encoding the Rstal gene with 13 nt spacing, only up to 9 mg/L p-coumaryl alcohol could be 
detected by HPLC in the supernatant. These results agree with the determined kinetic 
parameters of various plant derived tyrosine ammonia lyases as these enzymes generally 
display a low catalytic activity, which would explain the need for a maximization of  Rstal 
gene expression in E. coli (102-104). No significant trend for the translation efficiency of the 
three remaining proteins (Pc4CL, ZmCCR and ZmCAD) could be discerned after microtiter 
plate or shake flask screening experiments. Among the 27 variants with a 5 nt SD sequence-
START codon spacing for the Rstal gene, the 5-5-5-5 variant was one of the poorest 
producers accumulating up to 10.3 mg/L/OD600 p-coumaryl alcohol, supporting the notion 
that a maximum expression of all pathway genes has a negative effect on productivity. In 
comparison, the top five producers accumulated 14.6 – 16.1 mg/L/OD600 p-coumaryl-
alcohol in the supernatant after 12 h (variants: no. 12 (5-9-5-13); no. 14 (5-9-9-9); no. 15 (5-
9-9-13); no 18 (5-9-13-13); no. 23 (5-13-9-9). A decreased translation efficiency of the 
remaining three enzymes presumably decreased the metabolic burden for E. coli with 
respect to protein synthesis, which in turn balances the pathway and probably increases the 
availability of L-tyrosine for p-coumaryl alcohol synthesis. The levels of p-coumaric acid, the 
product of the RsTAL-catalyzed deamination, measured in the supernatant were always 
similar and considerably low (≤ 3 mg/L), indicating that the RsTAL-activity in E. coli was still 
limiting the overall product titer.  
The absolute product titers for the top five variants measured during shake flask 
experiments ranged from 47.6 to 52 mg/L without any further optimization of growth and 
production conditions. Compared to the previously engineered E. coli strain expressing the 
same genes, balancing of the synthetic pathway has already led to a doubling of the p-
coumaryl alcohol titers (99).  
Simultaneous construction of the 81 variants by combining all gene fragments with the 
vector backbone in a single reaction tube prior to hybridization and transformation to E. coli, 
resulted in the generation of an incomplete library. Even though the 5-9-9-9 variant was 
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found among the best clones during library screening, DNA sequencing of randomly selected 
clones revealed that not all E. coli clones harbored a complete synthetic p-coumaryl alcohol 
operon. Particularly the Zmcad gene was frequently missing. Incomplete pathway assembly 
was also observed during previous studies employing another phosphorothioate based 
cloning method (CLIVA), especially when the number of genes to be assembled increased 
(62). 
The PLICing method has proven to be a modular, simple and efficient cloning method, which 
could be used to set-up an automated cloning procedure in microtiter plate format. 
However, one has to bear in mind that the assembly efficiency decreases with increasing 
fragment numbers. To keep the number of fragments manageable, the modularity of the 
PLICing method can be used. When a certain configuration has been identified as most 
beneficial for the desired goal during an initial screening round as it was the case for the 5 nt 
SD sequence – START codon spacing of Rstal, this parameter can be fixed during later 
screening rounds. In case of the p-coumaryl alcohol operon, the Rstal gene fragment can be 
incorporated in the vector backbone, thereby reducing the number of fragments to be 
assembled during the construction of the next generation of synthetic operons. 
4.4 Suggestions to balance the heterologous gene expression in microorganisms 
During the combinatorial optimization of the p-coumaryl alcohol operon, only one 
parameter namely the SD sequence – START codon spacing was varied. However, other 
regulatory elements of gene transcription and mRNA translation such as promoters (105) or 
signal sequences such as metabolite-responsive riboswitches (106) could be varied during 
pathway balancing. Randomization of the gene order and/ or the number of copies of the 
individual genes could also represent opportunities for pathway balancing. For example 
increasing the gene dosage could be a solution to overcome low enzyme activity. 
 4.5 Conclusions 
By combining various metabolic engineering approaches and in vivo protein evolution of the 
heterologously expressed STS from Pinus strobus, microbial pinosylvin production from 
glucose could be successfully established in E. coli. However, addition of the fatty acid 
synthase inhibitor cerulenin is still required for sufficient product titers. Maximum product 
titers achieved in the presence of 200 µM cerulenin was 70 mg/L, while 91 mg/L could be 
reached with additional supplementation of 3 mM L-phenylalanine to the medium.
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The PLICing method proved to be a fast and efficient technique for the combinatorial 
assembly of multiple pathway configurations. However for rapid simultaneous construction 
of operon libraries in a single reaction, this method proved to be unfeasible due to a 
decreased assembly accuracy of complete operons. Systematic variation of the spacing 
between the Shine-Dalgarno sequence and the start codon efficiently modulated the 
expression of individual pathway genes and helped to balance the synthesis of the p-
coumaryl alcohol pathway enzymes to achieve high product titers. During the evaluation of 
81 pathway variants, tyrosine ammonia lyase activity proved to be the limiting step. 
Maximization of the translation efficiency of the respective mRNA was decisive for the 
construction of an E. coli strain, which accumulated up to 52 mg/L p-coumaryl alcohol in the 
supernatant.  
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6. Appendix 
6.1 Supplementary material ‘’Metabolic engineering of Escherichia coli for the 
synthesis of the plant polyphenol pinosylvin‘’ 
 
 
FIG S1 SDS-PAGE analysis of purified HisPdSTS3 and HisPstrSTS2 proteins. Expected 
molecular weight of HisPdSTS3 is 35.7 kDa and of HisPstrSTS2 is 44.8 kDa. Abbreviations: 
CFE: Cell free extract before column loading; FT: column flow through; Wash: wash 
fractions; Elu: Elution fractions. 
 
FIG S2 Intracellular malonyl-CoA concentrations in response to different cerulenin 
concentrations 1.5 hours after addition in E. coli BL21(DE3) (■) and the pinosylvin production 
strain E. coli BL21(DE3) pR-HisPstrsts2-Sc4cl-Pcpal1 (●).  
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6.2 Supplementary material ‘’Combinatorial optimization of synthetic operons for 
the microbial production of p-coumaryl alcohol with Escherichia coli’’ 
 
Table S1 Phosphorothioate oligonucleotides used in this study for the construction of the 
p-coumaryl alcohol operon libraries and oligonucleotides for the verification of the correct 
operon assembly via PCR. 
Primer Sequencea (5´-3´) 
Phosphorothioate oligonucelotides (PTOs) 
Vec_PTO_fw AGCaACTAaTAAgCTAAcAAAgCCCGaAAGgAAGCtGAG 
Vec_PTO_rv ACCtCCTtCTTaAAGTTAAACAAAATTATTTCTAGAGGGGAATTG 
RsTAL_5_fw TAAgAAGgAGGtATACCATGCTGGCTATGAGTCCTC 
RsTAL_9_fw TAAgAAGgAGGtGATCATACCATGCTGGCTATGAGTCCTC 
RsTAL_13_fw TAAgAAGgAGGtATCGGATCATACCATGCTGGCTATGAG 
RsTAL_uni_rv CCAcTTAtCCGgATGATTACTAGTGGGTTATTAAACTGGACTCTGTTGC 
Pc4CL_5_fw CCGgATAaGTGgAATAAGGAGGTATACCATGGGAGATTGTGTAGCAC 
Pc4CL_9_fw CCGgATAaGTGgAATAAGGAGGTGATCATACCATGGGAGATTGTGTAGC 
Pc4CL_13_fw CCGgATAaGTGgAATAAGGAGGTATCGGATCATACCATGGGAGATTGTG 
Pc4CL_uni_rv GAAcAGTgGATcATGATTACTAGTGGGTTATTATTTGGGAAGATCACCG 
ZmCCR_5_fw GATcCACtGTTcAATAAGGAGGTATACCATGACCGTCGTCGACGCCG 
ZmCCR_9_fw GATcCACtGTTcAATAAGGAGGTGATCATACCATGACCGTCGTCGACGC 
ZmCCR_13_fw GATcCACtGTTcAATAAGGAGGTATCGGATCATACCATGACCGTCGTC 
ZmCCR_uni_rv CTGaAGCaCTAgATGATTACTAGTGGGTTATTAGGCACGGATGGCG 
ZmCAD_5_fw CTAgTGCtTCAgAATAAGGAGGTATACCATGGGGAGCCTGGCGTCCG 
ZmCAD_9_fw CTAgTGCtTCAgAATAAGGAGGTGATCATACCATGGGGAGCCTGGC 
ZmCAD_13_fw CTAgTGCtTCAgAATAAGGAGGTATCGGATCATACCATGGGGAGCCTG 
ZmCAD_uni_rv AGCtTCCTtTCGgGCTTtGTTaGCTTaTTAgTTGCtGGCCGCATCCGC 
  
Colony PCR  primers 
RsTAL_end_fw GTTCAGGCACTGCGCGAACAGTTTC 
ZmCAD_start_rv ACCAACAACTTTACGTTCGGACGCCAG 
 
 
aLower case letters mark the locations of phosphorothioate bases. 
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